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Abstract 
Faithful segregation of homologous chromosomes during the first meiotic 
division (MI) is essential for the formation of haploid gametes. Recent research 
in our lab and others has shown that female ageing is associated with depletion 
of chromosomal cohesin and is accompanied by a marked decline in the ability 
of oocytes to segregate chromosomes synchronously during MI. This 
mechanism likely underlies the dramatic increase in infertility, miscarriage and 
birth defects that accompany female reproductive ageing. Here, I have used a 
mouse model and the transgenic Rec8-myc mouse strain to investigate 
mechanisms regulating chromosome segregation in oocytes and to identify 
pathways leading to missegregation during MI.  
 
I show for the first time that Plk1 is required for stepwise removal of cohesin, 
which is essential for normal segregation of chromosomes during meiosis. I 
found that a highly specific small-molecule inhibitor of Plk1 (BI 2536) inhibited 
APC/C-mediated degradation of securin, thereby preventing cleavage of 
cohesin by separase, which in turn prevents anaphase onset during MI.  By 
using a lower concentration of BI 2536, which was permissive for securin 
degradation, I unmasked a function for Plk1 in protecting centromeric cohesin 
during anaphase of MI. My findings indicate that loss of centromeric cohesin in 
the presence of BI 2536 is due to mislocalisation of the cohesin protector Sgo2. 
These data indicate that PLK1 kinase activity is essential for two key events 
required for normal segregation of chromosomes during MI.  
 
In somatic cells, Plk1 is involved in removal of cohesin by the separase-
independent prophase pathway, which removes the bulk of arm cohesin during 
prophase/prometaphase. My findings indicate that removal of cohesin during 
prophase is particularly relevant to the problem of female reproductive ageing. 
I show that age-related depletion of chromosomal cohesin occurs during the 
prolonged period of prophase arrest experienced by oocytes from older 
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females.  I also find that the cohesin protector Sgo2 is not recruited to 
chromosomes until the transition from prophase to prometaphase of MI and 
that its recruitment is impaired in cohesin-deficient oocytes. Moreover, I 
present data indicating that removal of cohesin by a Plk1-mediated mechanism 
is unlikely to contribute to the age-related loss of cohesin during progression 
through prometaphase of MI.  
 
Taken together the data indicate that Plk1 is essential for stepwise removal of 
cohesin in oocytes, but is not likely to be a major contributor to its loss during 
mammalian female ageing. Overall, these findings advance our understanding 
of the molecular mechanisms controlling chromosome segregation during 
meiosis I in mammalian oocytes, and how these are influenced by female 
reproductive ageing.  
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 1 
 : Introduction Chapter 1
1.1 Meiosis, aneuploidy and ageing: an overview 
Sexual reproduction is a means for the continuation of most eukaryotic species 
and in the same time the pinnacle of their evolutionary course in life. Sexual 
reproduction requires the fusion of two gametes, the specialised reproductive 
cells, one from each parent, which produces a single cell, the zygote, from 
which the new organism develops. To prevent duplication of the genomic 
material at each generation, sexual reproduction relies on a specialised form of 
cellular division, known as meiosis, which as the name implies in Greek 
(μείωσης), it reduces the genomic material of gametes by half. In diploid 
organisms, such as mammals, meiosis gives rise to haploid gametes via two 
sequential rounds of chromosome segregation – meiosis I (MI) and meiosis II 
(MII) – without an intervening round of DNA replication. MI is the reductional 
part of the meiotic programme, during which the recombinant paternal and 
maternal homologous chromosomes are segregated into two different cells. MII 
is the equational part, where sister-chromatid pairs are segregated by 
mechanisms that are almost similar to those used in mitotic division of somatic 
cells (Petronczki et al., 2003; Marston and Amon, 2004). 
 
As with every physiological process, cell division can fail. Deregulation of the 
mitotic programme has been identified as the malignant factor of a significant 
number of solid human cancers (Nakayama and Nakayama, 2006) and has been 
associated with neurodegenerative diseases, such as Alzheimer’s (Aulia and 
Tang, 2006). In most sexually reproducing organisms, meiotic errors are rare. 
However, in humans they appear to be more common and lead to the 
generation of gametes carrying an abnormal number of chromosomes, known 
as aneuploid gametes. Such abnormal gametes can give rise to embryos, which 
generally are non-viable and account for almost 50% of miscarriages occurring 
during the first semester of pregnancy (Suzumori et al., 2010). The few 
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aneuploid zygotes that are viable produce progeny with genetic birth defects, 
most common being the Down syndrome (trisomy 21). 
 
Figure 1.1 Incidence of trisomy in relation to maternal age. 
A graphical representation of the percentage of clinically recognized trisomic pregnancies in 
relation to maternal age. The risk for a trisomic pregnancy is exponentially increased after the 
late 30s for both trisomies 18 (green) and 21 (red), whereas for trisomy 16 (blue) it increases in 
an almost linear manner [modified from (Nagaoka et al., 2012)]. 
 
The majority of embryonic aneuploidies originate from the oocyte, rather than 
the sperm, and in particular from segregation errors during MI (Hassold and 
Hunt, 2001). More importantly, it appears that the frequency of meiotic errors 
increases rapidly as women age. Indeed, the probability of a trisomic pregnancy 
is known to reach 35% at the age of forty, from a mere 2% for a woman in her 
early twenties (Fig. 1.1) (Hunt and Hassold, 2010). Given that, if we also 
consider that it has become more commonplace for modern women to postpone 
childbirth, it would be easy to understand why in the last twenty years the 
incidence of Down syndrome pregnancies has increased by 71% in the UK 
(Morris and Alberman, 2009). The link between aneuploidies and ageing is 
most likely related to the extended meiotic arrest that occurs during 
mammalian female meiosis. As I will explain in more detail later, oocytes enter 
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meiosis during foetal development and remain arrested at MI until ovulation is 
triggered. In humans this state of limbo may last more than 40 years. 
 
Whilst the phenomenon of age-related aneuploidies has been well established, 
the meiotic programme is so intricate that the molecular basis of segregation 
errors is not yet well defined. In this otherwise magically tuned and flawlessly 
orchestrated dance of chromosomes that takes place on the meiotic stage, there 
has to be at least one culprit responsible for the aneuploid confusion in the 
grand finale. Like a passionate lover of the theatre of life, this thesis sets out to 
uncover this felon. 
1.2 Mechanisms for successful chromosome segregation 
Chromosome segregation is essentially a mechanical process involving a 
structural lattice of microtubules (Mts) known as the spindle, which segregate 
chromosomes under the control of biochemical signals. The biochemical signals 
are largely generated from the kinetochore (Kt), a complex assembly of proteins 
at the primary constriction (centromere), which forms the attachment site 
between chromosomes and the Mts of the spindle.  The biochemical signals 
generated from unattached Kts act as a surveillance mechanism known as the 
spindle assembly checkpoint (SAC). The SAC monitors the attachment of the 
spindle to all Kts, thereby ensuring the genomic material will be accurately 
segregated between daughter cells upon the onset of anaphase (Musacchio and 
Salmon, 2007). Most importantly, during mitosis, sister chromatids need to be 
tightly aligned on the metaphase plate (spindle equator) and establish correctly 
oriented attachments with the spindle microtubules. In order to accomplish that 
sister chromatids are held together by sister chromatid cohesion, which is 
mediated by protein complexes known as cohesins (Nasmyth and Haering, 
2009) . Upon SAC satisfaction and the onset of anaphase, chromosome 
disjunction is triggered through the cleavage of cohesin by a protease known as 
separase (Uhlmann et al., 2000; Waizenegger et al., 2000). Until that point and 
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for most of the cell cycle, separase is kept inactive by being sequestered by an 
inhibitory chaperon known as securin and through phosphorylation by 
Cdk1/cyclin B (Yamamoto et al., 1996; Stemmann et al., 2001a). Activation of 
separase is achieved when all chromosomes have bioriented, through the 
ubiquitination of securin and cyclin B by the anaphase-promoting complex or 
cyclosome (APC/C) and their subsequent degradation by the proteasome 
[reviewed by (Peters, 2006)]. 
1.2.1 The Spindle 
The spindle is a complex, highly dynamic structure made up off tubulin 
polymers (microtubules) and microtubule-associated proteins, such as 
molecular motors that use chemical energy to perform mechanical labour. The 
meiotic spindle in mammalian oocytes differs from the somatic cell mitotic 
spindle in several aspects. In somatic cells spindle positioning is mediated by 
astral microtubules in both symmetric and asymmetric divisions, whereas astral 
microtubules are absent in meiosis and the spindle is asymmetrically positioned 
through the action of the actin-filament network (Verlhac et al., 2000; Schuh and 
Ellenberg, 2008). Another major difference is that mammalian oocytes do not 
have “traditional” centrosomes, as they lack centriole pairs. Instead, 
microtubule nucleation and coordination is performed by microtubule 
organising centres (MTOCs), which undergo a striking cell-cycle dependent 
remodeling (Maro et al., 1985; Messinger and Albertini, 1991). As discussed 
below, recent 3D live-cell (4D) imaging studies have verified the significance of 
MTOCs in the assembly of the meiotic spindle and have provided a unique 
insight into spindle-chromosome interactions during meiotic maturation (Schuh 
and Ellenberg, 2007; Kitajima et al., 2011). 
 
The first phenotypical hallmark of meiosis I resumption is germinal vesicle 
breakdown (GVBD), the equivalent of nuclear envelope breakdown (NEB) in 
somatic cells. Before GVBD, chromosomes are partially condensed around the 
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nucleolus, although not to an extent where homologue pairs can be 
microscopically distinguished. In a study by Schuh and Ellenberg, the authors 
have used 4D confocal fluorescence microscopy to quantitatively analyse the 
functional dynamics of single MTOCs, bivalent chromosomes, and microtubule 
plus ends during meiosis I spindle assembly at high spatial and temporal 
resolution (Schuh and Ellenberg, 2007). According to this study, in mice, the 
first few hours following GVBD chromosomes condense further and a bipolar 
spindle is gradually formed through the coalescence of MTOCs. Approximately 
80 MTOCs, which form during prophase from a network of cytoplasmic 
microtubules, migrate to the centre of the oocyte and gradually merge from a 
multipolar spindle into a bipolar spindle that elongates and captures the 
condensed chromosomes. During most of prometaphase I, chromosome 
movement is performed by microtubules associated with chromosome arms. 
Finally, at 4 hours after GVBD, at metaphase of MI, chromosomes appear to 
have aligned on the metaphase plate of a centrally localized, barrel-shaped 
spindle structure. Interestingly, the bipolar meiosis I spindle appears to form 
due to the actions of MTOCs, rather than due to any chromosome-induced 
effect (Brunet et al., 1998; Schuh and Ellenberg, 2007). Moreover, stable end-on 
Kt-Mt interactions appear to be established just a short time prior to anaphase   
(Brunet et al., 1999; Schuh and Ellenberg, 2007).  
 
In another study, Kitajima and Ellenberg have performed 4D confocal 
fluorescence imaging of meiosis I in mouse oocytes expressing kinetochore 
proteins fused to GFP (Kitajima et al., 2011). Using a kinetochore tracking 
approach, where distances between centromeres in paired homologues were 
monitored, the authors reported that chromosomes form an intermediate 
configuration, the prometaphase belt; initially, condensing chromosomes 
arrange as a spherical shell around microtubules and then congress and become 
gradually ordered to form a ring structure in the equatorial region surrounding 
microtubules. A similar phenomenon has also been observed during mitosis 
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(Magidson et al., 2011). Next, chromosomes invade the elongating spindle 
structure centre, align on the metaphase plate and gradually become bi-
oriented. Furthermore, it was shown that multiple Kt-Mt attachment attempts 
are required to achieve biorientation of homologous chromosomes in late 
metaphase I and that Aurora B kinase is essential for the correction of erroneous 
Kt-Mt attachments. This finding is of particular interest, given the high 
incidence of aneuploidies of mammalian oocytes, due to meiosis I chromosome 
segregation errors. 
1.2.2 The Anaphase Promoting Complex / Cyclosome 
Under physiological conditions, the cell cycle comprises a predefined sequence 
of irreversible biochemical phenomena. One of the ways that this irreversible 
character is established is through the proteolytic degradation of the proteins 
that regulate the transitions along the stages of the cell cycle. The leading 
cellular mechanism that controls proteolysis is the process of ubiquitination 
(Hershko, 2005). The APC/C is a major component of this mechanism; therefore 
its activity is intimately associated with the progress of the cell cycle. 
 
The APC/C is composed of 11-13 different subunits most of which have been 
conserved from yeast to animal cells (Baker et al., 2007). Phosphorylation of 
these subunits at multiple sites is also required for APC/C activation (Pines, 
2006). The functions of most other APC/C subunits is not clear, and although it 
has been suggested that some of them may play a more essential role in meiosis 
than in mitosis, the question why APC/C is so complex still remains open. 
 
Another fact that underlines the highly important role of APC/C is that its 
activity is finely tuned by a complex system of kinases, activators and 
inhibitors. Activators are essential for APC/C activity, bind to it at different 
times during mitosis/meiosis and control its substrate specificity.  Two 
activators, Cdc20 and Cdh1 which belong to the family of WD40 proteins, give 
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rise to APC/CCdc20 and APC/CCdh1 respectively, and are of particular importance. 
Other activators include Mfr1 and Ama1 (in yeast) and Fzr2 and Cortex (in 
Drosophila), which are meiosis-specific and their functions have not been fully 
understood (Acquaviva and Pines, 2006). APC/C inhibitors include the mitotic 
checkpoint complex (MCC), the early mitotic inhibitor 1 (Emi1) and its 
homologue Emi2/XErp1, the tumour suppressor Ras association domain family 
1 (Rassf1A), the APC/CCdh1 modulator 1 (Acm1), the nuclear transport factors 
Nup98 and Rae1, and Mes1 (Pesin and Orr-Weaver, 2008). Most of these 
inhibitors act by directly binding activators, thus restricting APC/C activation. 
 
In addition to the well investigated mechanism of modulation of APC/C 
activity through control of Cdh1 and Cdc20 levels, there is evidence that APC/C 
activity is also regulated by direct phosphorylation. A number of kinases, 
including Cdk1/cyclin B, Polo-like kinase 1 (Plk1) and protein kinase A (PKA) 
are known to regulate APC/C function through the phosphorylation of 
numerous residues (Kraft et al., 2003; Baker et al., 2007). Once somatic cells have 
entered mitosis, the APC/C is partially activated by Cdk1/cyclin-dependent 
phosphorylation (Rudner and Murray, 2000; Kraft et al., 2003). In particular, B-
type cyclins phosphorylate numerous APC/C subunits, thereby increasing the 
affinity of Cdc20 to the APC/C (Shteinberg et al., 1999; Rudner et al., 2000; 
Rudner and Murray, 2000; Kraft et al., 2003). In S. cerevisiae, phosphorylation by 
Cdk1/cyclin B has been reported to determine APC/C activator-binding 
specificity, thus promoting Cdc20 binding during mitosis and Cdh1 binding 
during mitotic exit and interphase. Indeed, mutating the Cdk1/cyclin B 
phosphorylation sites on the APC/C promotes Cdh1 binding during mitosis, 
instead of Cdc20 (Cross, 2003). 
 
Nevertheless, it is still unclear whether Cdk1/cyclin-dependent 
phosphorylation is the sole mechanism of APC/C activation in mitosis. Early 
studies have shown that APC/C activation may require phosphorylation by 
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Plk1 (Kotani et al., 1998). Moreover, the APC/C inhibitor Emi1 has been 
proposed to be targeted for degradation by the SCFβTrCP once phosphorylated by 
Plk1 (Reimann et al., 2001a; Hansen et al., 2004; Moshe et al., 2004). However, 
recent studies have shown that in the presence of a non-degradable form of 
Emi1 (Di Fiore and Pines, 2007), or with chemical Plk1-inhibition (Lenart et al., 
2007), the activation of APC/C is not obstructed. 
 
Although it is still unclear which characteristics of a target protein allow its 
recognition by the ACP/C complex, it has been shown that the target proteins 
contain specific sequence motifs, known as degradation motifs (or degrons), 
which are necessary for their ubiquitination. One important motif is 
RxxLxxxxN (R for arginine; X any amino-acid; L for leucine; N for asparagine), 
which is known as the destruction box (D-box) (Prinz et al., 1998). Another 
motif is KENxxxN (K for lysine; E for glutamate) which is given the name KEN-
box (Pfleger and Kirschner, 2000). The KEN-box is preferentially recognised by 
ACP/CCdh1, whereas ACP/CCdc20 can recognise only the D-box. Other degrons, 
such as the A-box, the O-box and the CRY-box have also been described 
[reviewed in (Barford, 2011)]. 
1.2.3 The Spindle Assembly Checkpoint 
During mitosis separase activity is highly regulated by the inhibitory binding of 
securin (Yamamoto et al., 1996) and the Cdk1/cyclin B complex (Stemmann et 
al., 2001b; Gorr et al., 2005). The APC/C together with its activator Cdc20, 
promotes the ubiquitination and subsequent degradation of securin and cyclin 
B, thus promoting separase activation (Fig 1.2). However, before APC/CCdc20 can 
degrade its substrates to promote anaphase, the SAC has to be satisfied. In 
general, this is achieved through the activity of the MCC, a complex comprising 
the conserved checkpoint proteins Mad2, Bub3, BubR1 and Cdc20, which 
inhibits APC/CCdc20 from targeting cyclin B and securin for degradation 
[reviewed in (Musacchio and Salmon, 2007)] (Fig 1.2). The exact mechanism of 
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inhibition has not been fully unveiled yet and recent evidence suggests that 
different inhibitory protein complexes may operate during the SAC in different 
organisms and that the MCC is just a transient step in the activation of the SAC 
(Eytan et al., 2008; Nilsson et al., 2008; Kulukian et al., 2009).  
 
Although the SAC is the principal regulatory mechanism of APC/C activity 
during mitosis [reviewed in (Nasmyth, 2005; Musacchio and Salmon, 2007)], in 
meiosis its role still remains controversial. Studies focusing on SAC function in 
vertebrate oocytes have proven it to be present and active. Preliminary 
experiments using XO mice (mice carrying a single X chromosome), suggested 
that the vertebrate meiotic SAC was inefficient in detecting misaligned 
chromosomes (LeMaire-Adkins et al., 1997). However, later evidence showed 
that biorientation of sister chromatids, instead of bivalents, is probably the 
reason XO oocytes evade the SAC (Kouznetsova et al., 2007). Mad2, Bub1 and 
BubR1 are present in vertebrate oocytes and perturbation or loss of their 
function leads to premature resolution of chiasmata, failure to biorient 
bivalents, premature onset of anaphase and chromosome missegregation in MI 
(Wassmann et al., 2003; Zhang et al., 2004; Homer et al., 2005a; Homer et al., 
2005b; Niault et al., 2007; Homer et al., 2009a; McGuinness et al., 2009). In 
contrast to mitosis, where the presence of a single unattached kinetochore 
effectively inhibits anaphase (Rieder et al., 1994; Rieder et al., 1995), in MI the 
SAC appears to be notoriously error-prone (Hassold and Hunt, 2009) and 
various hypotheses have been proposed to explain this paradox (Hoffmann et 
al., 2011; Nagaoka et al., 2011; Gui and Homer, 2012; Lane et al., 2012). 
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Figure 1.2 Regulation of the APC/C by the SAC 
During early mitosis unattached kinetochores (Kts) promote the formation of the mitotic 
checkpoint complex (MCC), which consists of BubR1, Cdc20, Mad2 and Bub1. The MCC leads 
to inhibition of the APC/C by sequestering its activator Cdc20. Once all Kts establish end-on 
attachments with spindle microtubules and align on the metaphase plane, Cdc20 is released 
and activates the APC/C, which ubiquitinates securin and cyclin B, thereby tagging them for 
degradation by the 26S proteasome. Degradation of securin releases separase, which cleaves 
cohesin and allows anaphase to occur. Cyclin B degradation inactivates Cdk1, thus leading to 
exit from mitosis. 
  
1.2.4 Establishment and resolution of cohesion in mitosis 
Mitosis is a complex process during which the duplicated genome coming from 
the S-phase (DNA replication) is equationally segregated into two new 
daughter nuclei (Fig. 1.3.A). Following mitosis, the cell divides by cytokinesis to 
produce two daughter cells with identical genomes. This process is repeated in 
mammalian somatic cells contributing to the growth, development and 
maintenance of the organism. 
 
During mitosis, sister chromatid cohesion is mediated by the multi-subunit 
cohesin complex (Fig. 1.4). Cohesin was first identified in Saccharomyces 
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cereviciae (Guacci et al., 1997; Michaelis et al., 1997; Toth et al., 1999) and was 
found to comprise of four core subunits: two subunits of the structural 
maintenance of chromosomes (SMC) protein family, Smc1 (also known as 
Smc1α in vertebrates) and Smc3; the kleisin family protein Scc1/Rad21; and an 
accessory subunit Scc3. According to the currently prevalent model, cohesin 
fulfills its role by forming a ring-like structure which encircles sister chromatids 
(Fig 1.4) (Gruber et al., 2003; Uhlmann, 2004; Nasmyth and Haering, 2005; 
Nasmyth, 2011). Cohesin protein subunits are highly conserved among 
eukaryotes, from yeasts to vertebrates. In vertebrates two isoforms of Scc3 are 
expressed and are known as SA1 and SA2 (Losada et al., 2000). The important 
role of cohesin subunits has been underscored in various experiments, where 
their depletion leads to chromosome segregation errors and increased levels of 
aneuploidy (Sonoda et al., 2001; Hoque and Ishikawa, 2002). 
 
Cohesin is recruited to chromosomes before S-phase, a process mediated by the 
Scc2/Scc4 cohesin-loading complex (Ciosk et al., 2000; Tomonaga et al., 2000), 
and appears to be enriched around the centromeres and at several sites along 
chromosome arms (Blat and Kleckner, 1999; Tanaka et al., 1999). During S-
phase, other factors including Ctf4, Ctf18 and the acetyl-transferase Eco1 
facilitate the cohesin-dependent pairing of the emerging sister chromatids (Toth 
et al., 1999) and consistently colocalise with DNA replication forks (Lengronne 
et al., 2006). In fission yeast and mammals, the heterochromatin protein 
HP1/Swi6 facilitates the enrichment of cohesin at pericentromeric regions 
suggesting that the establishment of strong centromeric cohesion to counteract 
the pulling forces of spindle microtubules is of outmost importance, as this 
mechanical phenomenon essentially ensures the bipolar attachment of 
chromosomes (Pidoux and Allshire, 2004). 
  
 12 
 
Figure 1.3 Chromosome segregation during Mitosis and Meiosis 
A simplified schematic representation of chromosome segregation in mitosis and meiosis: (A) In 
vertebrate somatic mitosis, sister kinetochores are attached to spindle microtubules emanating 
from opposite poles. Prior to anaphase, sister chromatid cohesion mediated by Scc1/Rad21-
cohesin is removed, allowing sister chromatid separation. (B) In mammalian female meiosis, the 
Scc1/Rad21 subunit is replaced by Rec8. During prometaphase I, sister kinetochores of 
recombined homologues attach to spindle microtubules emanating from the same pole. 
Cleavage of chromosome-arm cohesin allows separation of homologues, with one of them 
being extruded within the 1st polar body. Upon fertilisation, centromeric cohesin is removed 
and sister chromatids separate as in mitosis, with one sister chromatid being extruded within 
the 2nd polar body [modified from (Sakuno and Watanabe, 2009)]. 
 
  
1st polar body 
2
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A B 
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Figure 1.4 The cohesin complex 
In somatic vertebrate cells, the cohesin core complex consists of the subunits Smc1, Smc3, Scc1, 
and either SA1 or SA2. In mammalian meiosis the synthesis of cohesin alters, with Scc1 being 
substituted by Rec8 or Rad21L, Smc1 by Smc1β and SA1/2 by SA3/Stag3. According to the 
“ring” model, cohesin mediates SCC by forming a tripartite ring that entraps sister chromatids 
[modified from (Peters et al., 2008)].  
 
In order for sister chromatids to separate during anaphase, cohesin needs to be 
removed (Fig 1.5). In yeast, a specific protease known as separase (Esp1 in S. 
cerevisiae, Cut1 in S. pombe ) is activated at the onset of anaphase and cleaves the 
Scc1/Rad21 subunit, thus breaking open the cohesin ring and allowing sister 
chromatids to be pulled apart (Uhlmann et al., 1999; Uhlmann et al., 2000; 
Uhlmann, 2003). In vertebrates, however, the bulk of cohesin is removed from 
chromosome arms during prophase prior to separase activation, via a process 
known as the “prophase pathway” (Losada et al., 1998; Sumara et al., 2002). This 
process does not require the cleavage of Scc1/Rad21 by separase, as cohesin 
dissociation is achieved through phosphorylation of SA1/2 by Polo-like kinase 
1(Plk1) mediated by Aurora B (Hauf et al., 2005) and Wapl (Gandhi et al., 2006; 
Kueng et al., 2006). During this process, centromeric cohesin is protected by the 
protein shugoshin (Sgo; Japanese 守護神 for “guardian spirit”), which together 
with protein phosphatase 2A (PP2A) counteract cohesin phosphorylation until 
the onset of anaphase (Katis et al., 2004; McGuinness et al., 2005; Kitajima et al., 
2006; Riedel et al., 2006). Once the cell reaches the metaphase-anaphase 
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transition, separase is activated to cleave the remainder centromeric cohesin 
and allow sister chromatid segregation. 
1.2.5 Establishment and resolution of cohesion in meiosis 
Meiotic division (Fig. 1.3.B) is fundamental for the production of functional 
gametes and is a much more intricate and specialised programme than mitosis. 
Its level of complexity is well reflected by the increased levels of cohesin 
regulation through the activity of both mitotic and meiosis-specific 
mechanisms. 
 
As in mitosis, meiotic cohesion is established during the pre-meiotic S-phase, 
however meiosis-specific cohesin subunits are also employed. In budding yeast, 
fission yeast and mammals, Scc1/Rad21 is largely replaced by its meiotic 
counterpart Rec8 (Klein et al., 1999; Watanabe and Nurse, 1999; Pasierbek et al., 
2001) and the mammal-specific Rad21L (Gutierrez-Caballero et al., 2011; Herran 
et al., 2011; Ishiguro et al., 2011; Lee and Hirano, 2011). In mammalian germ cells 
further alterations include the replacement of SA1/2 by SA3/STAG3 (Pezzi et al., 
2000; Prieto et al., 2001), and Smc1α by Smc1β (Revenkova et al., 2001). Various 
localization studies on these meiosis-specific cohesin variants have revealed 
differential chromosome distribution patterns throughout meiosis (Prieto et al., 
2004; Revenkova and Jessberger, 2005; Sakuno and Watanabe, 2009; Jessberger, 
2011), suggesting that different cohesin complexes might have unique 
functions. However, across all organisms Rec8 appears to play a predominantly 
significant role.  Whereas Rad21L is not detectable in metaphase I oocytes 
(Ishiguro et al., 2011), Rec8 is recruited earlier than other cohesin subunits, is 
removed later from chromosome arms in MI and remains at the core 
centromeric regions until the metaphase-anaphase II transition (Fig. 1.5) (Eijpe 
et al., 2003). In addition, various experiments involving RNAi depletion of Rec8 
and Rec8 mutations have revealed several effects including premature loss of 
cohesion, reduction or failure of recombination and increased aneuploidy and 
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infertility (Klein et al., 1999; Watanabe and Nurse, 1999; Pasierbek et al., 2001; 
Xu et al., 2005). 
 
Figure 1.5 Protection of centromeric cohesin by shugoshin-PP2A in mitosis 
and meiosis. 
During prometaphase of vertebrate meiosis, cohesin is removed from chromosome arms via 
Plk1-mediated phosphorylation. This mechanism is known as the “prophase pathway”. The 
shugoshin-PP2A complex protects pericentromeric cohesin until the onset of anaphase, when it 
is removed to allow the cleavage of cohesin by separase. In meiosis, during anaphase I, 
shugoshin-PP2A protects centromeric cohesin from cleavage by separase, until metaphase II, 
thus allowing accurate segregation of homologous chromosomes. With the onset of anaphase II, 
protection is removed and sister chromatids are separated into individual gametes [adapted 
from (Sakuno and Watanabe, 2009)]. 
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One of the issues in meiosis is that segregation of the genomic material has to 
occur twice, without being interrupted by an S-phase. This is essential for 
haploid gametes to be generated. This scenario requires that homologous 
chromosome pairs (bivalents) and sister chromatids must be segregated 
separately in MI (reductional segregation) and MII (equational segregation), 
respectively, thereby imposing specific adaptations to the meiotic process. 
 
As with sister chromatids, the pairs of homologous chromosomes must be 
somehow bonded to establish tension between them to counteract the pulling 
force of spindle microtubules. The establishment of physical linkages between 
paternal and maternal homologues occurs during early meiotic prophase, and 
is known as meiotic recombination or crossover formation, which involves 
reciprocal exchange of DNA between non-sister chromatids (Kleckner, 2006). 
Following crossover formation the physical linkages between recombined 
homologues become visible at cytologically distinct structures known as 
chiasmata. However, chiasmata hold homologues together in MI only because 
they are stabilized by sister chromatid cohesion on chromosome arms, distal to 
the chiasmata (Moore and Orr-Weaver, 1998; Petronczki et al., 2003). 
Furthermore, studies on Rec8 and Smc1β deficient mice have shown that these 
proteins are involved in meiotic recombination and stabilisation of chiasmata 
(Bannister et al., 2004; Revenkova et al., 2004; Xu et al., 2005). 
 
Proper homologue segregation during MI means that sister chromatids need to 
attach to microtubules that will pull them towards the same spindle pole. This 
is known as monopolar kinetochore-microtubule attachment of sister 
chromatids (Fig. 1.3.B) (Hauf and Watanabe, 2004; Brar and Amon, 2008) and 
depends on sister centromeres being closely apposed. In this case, centromeric 
cohesin is responsible for keeping sister centromeres tightly bound. In yeast, 
proteins known as monopolins have also been shown to be essential for 
monopolar attachment (Toth et al., 2000; Yokobayashi and Watanabe, 2005). 
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Finally, cohesin on chromosome arms of sister chromatids must be cleaved for 
MI to occur, whereas centromeric cohesin must remain intact until the onset of 
anaphase II, as it is essential for biorientation of sister chromatids before 
anaphase of MII. In both MI and MII, segregation is achieved by the breakdown 
of cohesin complexes through the same mechanism that has been described in 
mitosis, involving APC/C-dependent activation of separase (Buonomo et al., 
2000; Kudo et al., 2006). However, to achieve chromosome arm-specific loss of 
sister chromatid cohesion in meiosis I, centromeric cohesin is protected from 
cleavage by either of two shugoshin isoforms, Sgo1 and Sgo2 (paralogs of MEI-
S332 in Drosophila melanogaster) (Kitajima et al., 2004). This allows 
homologues to separate, while sister chromatids remain attached together (Fig. 
1.5). In MII, protection is removed from the centromeres and separase is able to 
cleave cohesin and promote the segregation of sister chromatids (Watanabe, 
2005). S. cerevisiae and D. melanogaster have only one known shugoshin (Sgo1 
and MEI-S332, respectively), whereas S. pompe, Xenopus laevis and mammals 
have two (Sgo1/SGOL1 and Sgo2/SGOL2) (Gutierrez-Caballero et al., 2012). 
Although shugoshins are considered orthologs, they share little sequence 
homology and exhibit divergence in their functions among different species. 
For example, whereas Sgo1 is considered to be the guardian of meiotic 
centromere cohesion in yeast (Kitajima et al., 2004) and flies (Kerrebrock et al., 
1995), resent studies have shown that in mammals Sgo2 is solely responsible 
and Sgo1 dispensable for protection of centromeric cohesin during meiosis (Lee 
et al., 2008; Llano et al., 2008). 
 
It is evident that cohesin is a key component of all the fundamental meiotic 
mechanisms described above. Consequently, it is easy to understand why 
cohesin-related anomalies can cause chromosome missegregation and thus 
aneuploidy. In other words, accurate regulation of the cohesin complex is one 
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of the most central features of faithful chromosome segregation therefore it is 
important to understand the precise molecular mechanisms that surround it. 
 
1.3 Development of mammalian germ cells 
Mammalian germ cells (female oogonia and male spermatogonia) originate 
from primordial germ cells (PGCs), which migrate to the genital ridge during 
embryonic development to form the gonad. There, expression of sex-
determining genes on the Y chromosome promote testicular development, 
whereas in their absence a female gonad develops (Gilbert, 2006). 
1.3.1 Oogenesis 
The development of female germ cells into mature oocytes is known as 
oogenesis and is initiated before birth (Fig. 1.6). In mice, oocytes start 
undergoing meiosis (primary oocytes) in the fetal ovary from embryonic day 
13.5. In the human embryo, primary oocytes appear around the second month 
of gestation and oogonia continue to divide mitotically until the seventh month 
(Peters, 1970). During this developmental stage, maternal and paternal 
homologues pair and undergo reciprocal exchange of DNA. After birth, 
primary oocytes enter arrest in prophase of meiosis I, which is also known as 
the dictyate arrest. For the most part, prophase arrest is spent in the primordial 
stage, when the oocytes are not yet been recruited for growth.  The fully grown 
oocytes becomes responsive to hormonal signals, which trigger exit from 
prophase arrest and entry into prometaphase of MI. Ovulation occurs once MI 
has been completed and the oocyte arrests at metaphase of MII until it is 
fertilized or otherwise activated. At this stage oocytes have a visible nucleus, 
called the germinal vesicle (GV; Fig. 1.7.A) and remain arrested there, until they 
receive the necessary hormonal signals to resume meiosis, or become atretic 
and perish (Jones, 2008). 
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With the onset of puberty, cyclical hormone stimuli are activated that promote 
oocyte maturation and ovulation. The effects of periodically secreted 
gonadotropins (follicle-stimulating hormone, FSH; luteinising hormone, LH) 
stimulate fully grown oocytes to make the transition from prophase arrest to 
prometaphase of MI, until they become arrested again at metaphase of MII 
prior to ovulation (Jones, 2008). Resumption of MI is marked by germinal 
vesicle breakdown (GVBD; Fig. 1.7.B).  The completion of MI yields a secondary 
oocyte, in which half the chromosomes have been “discarded” into a tiny 
structure known as the first polar body (Fig. 1.7.C). Upon fertilisation, the 
secondary oocyte quickly completes MII to produce a second polar body and a 
haploid oocyte. The latter, together with the sperm will form the zygote, giving 
rise to a new organism (Gilbert, 2006). 
 
Overall, during vertebrate oogenesis, meiosis is arrested twice, in prophase I 
and in metaphase II. Although the exact mechanisms have not been elucidated 
yet, it is known that APC/C activity must be highly regulated during both 
meiotic arrests. In mouse oocytes APC/CCdh1-mediated degradation of substrates 
appears to be necessary for maintaining prophase I arrest and its inhibition by 
Emi1 contributes to resumption of MI (Reis et al., 2006a; Marangos et al., 2007; 
Reis et al., 2007). The metaphase II arrest is also known as the cytostatic factor 
(CSF) arrest and its function is to prevent egg activation prior to fertilisation. 
According to the currently accepted model, the MetII arrest is generated 
primarily due to the inhibition of APC/CCdc20 by the protein Emi2/XErp1 (Gui 
and Homer, 2012) (Madgwick et al.; Lane et al., 2012) 
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Figure 1.6 The development of human germ cells 
In both foetal testis and ovary, germ cells proliferate mitotically. However, they enter meiosis at 
markedly different stages through their development. Males: In the foetal testis male germ cells 
initially proliferate mitotically for a short period and then enter mitotic arrest. After birth 
spermatogonia resume mitotic proliferation and with the onset of puberty they begin to 
differentiate and mitotically divide into sperm cells. Spermatogonia continue to proliferate and 
produce sperm virtually throughout the lifetime of a male. Females: In the foetal ovary the brief 
period of proliferation is directly followed by entry into meiosis, while in the same time a 
significant number of oogonia become apoptotic. The remaining oogonia enter dictyate arrest 
prior to birth and begin forming primordial follicles by being surrounded with somatic cells. At 
puberty, small cohorts of primary follicles are periodically induced to mature via hormonal 
stimuli and typically each month a single secondary oocyte is ovulated, while the rest of the 
primary oocytes succumb to atresia. This process continues until the pool of oocytes is depleted 
and the female enters menopause [modified from (Hassold and Hunt, 2001)]. 
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Figure 1.7 Meiosis in mouse oocytes 
A timeline of oocyte maturation: (A) A primary oocyte at dictyate arrest, with a visible germinal 
vesicle (GV) and nucleolus. (B) Germinal vesicle breakdown (GVBD) marks the resumption of 
meiosis I. (C) Polar body (PB) extrusion signals completion of MI and arrest at metaphase II. 
 
As mentioned previously, cohesin is recruited during S-phase, which takes 
place during fetal development, and is totally removed at the onset of anaphase 
II, which occurs upon fertilisation. Considering the developmental profile of 
mammalian oocytes, the time interval between recruitment and removal of 
cohesin is amazingly long, as in humans it could last until the onset of 
reproductive senescence (~40-50 years long). During such a prolonged period, 
cohesin might degrade and become defective, thus causing destabilisation of 
chiasmata and premature segregation of sister chromatids. From that 
perspective, cohesin could be the perfect link between reproductive age and 
aneuploidy. 
1.3.2 Spermatogenesis 
Spermatogenesis is the process by which male spermatogonia develop into 
mature spermatozoa, also known as sperm cells (Fig. 1.6). In the mammalian 
embryonic testis, immature spermatogonia enter a phase of mitotic arrest at 
G0/G1 early during development (~13.5 days post coitum in mice) and remain 
there until birth (de Rooij and Grootegoed, 1998). In mice, a few days after 
birth, spermatogonia begin to proliferate mitotically and through successive 
differentiation steps they enter MI and initiate spermatogenesis. Development 
from stem cell to spermatozoon takes 34.5 days. In human males, 
spermatogenesis begins with the onset of puberty and development takes 
almost twice as long.  Nevertheless, each day nearly 100 million “fresh” 
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spermatozoa are made in each testicle and during his lifetime a human male 
can produce 1012 to 1013 sperm (Reijo et al., 1995; Gilbert, 2006). 
1.4 Meiotic Maturation in Mouse Oocytes 
Meiosis is the process by which diploid germ cells generate haploid gametes. 
As previously described, in females meiosis begins during fetal development 
and exhibits two arrest stages (Prophase I and Metaphase II). According to the 
widely accepted dogma, females are born with a finite cohort of oocytes, a big 
part of which become apoptotic during prophase I arrest (Beaumont and 
Mandl, 1961; Byskov, 1974; Coucouvanis et al., 1993).  Developing oocytes are 
surrounded by granulosa cells, which support their growth (Eppig, 2001). 
During the prolonged prophase I arrest, granulosa cells increase in numbers 
and oocytes grow in size, while accumulating the necessary transcripts to 
support meiotic maturation, fertilisation, and preimplantation development 
(Moore, 1975; Sorensen and Wassarman, 1976; Moore and Lintern-Moore, 1978). 
Fully-grown, meiotically competent oocytes are contained within large antral 
follicles. Upon receiving ovulatory signals, these oocytes escape prophase 
arrest, complete MI, extrude the first polar body polar body and arrest at 
metaphase II. Upon fertilization, a second polar body is extruded and MII is 
completed. The stages between MI resumption and Met-II arrest are collectively 
referred to as meiotic maturation. 
 
During meiotic maturation a plethora of protein kinases and phosphatases 
engage in a highly dynamic play in order to regulate the process (Schultz et al., 
1983; Bornslaeger et al., 1986; Bornslaeger et al., 1988). At the moment we know 
that the mouse genome encodes a total of 162 protein phosphatases and 561 
protein kinases (Roy and Cyert, 2009). During recent years research has focused 
on key players of these protein groups and a constantly increasing number of 
them appear to be essential in the regulatory pathways that control oocyte 
meiotic maturation. Among the many kinases, Plk1 has been shown to have a 
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multitude of functions during mitosis and is therefore established as an 
important regulator of mitotic phenomena. However, very little is known to 
date about the meiosis-specific functions of Plk1. 
 
1.5 Polo-like kinase 1 
The serine/threonine kinase known as Polo was discovered almost 25 years ago 
in Drosophila (Sunkel and Glover, 1988; Llamazares et al., 1991). Polo kinase is 
highly conserved among eukaryotes and its orthologues include Plk1 in 
mammals (Fig 1.8), Plx1 in Xenopus, Cdc5 in S. cerevisiae and Plo1 in S. pombe 
(Archambault and Glover, 2009). Extensive research has established Plks as key 
regulators of cell proliferation in all model organisms where they have been 
studied to date. Currently, in humans, the PLK family includes five members 
(PLK1-5), with PLK1 being arguably the most important member in regulating 
mitotic and meiotic divisions (Lens et al., 2010). All Plks contain a C-terminal 
Polo-box domain (PBD), which allows them to interact with target proteins. In 
vertebrate cells Plk1 controls a number of processes, including mitotic entry, 
centrosome maturation, bipolar spindle assembly, microtubule (Mt)-
kinetochore (Kt) attachments, release of cohesin from chromosome arms 
(prophase pathway), APC/C activation and cytokinesis (Fig 1.8) [reviewed in 
(van de Weerdt and Medema, 2006; Petronczki et al., 2008; Archambault and 
Glover, 2009)]. Consistent with its multiple functions, Plk1 localises to various 
subcellular sites, mediated by its phospho-binding PBD (Elia et al.; Elia et al., 
2003b).  
 
Most of research on Plk1 has focused on its multiple functions in mitosis. 
During interphase Plk1 is diffusely distributed throughout the cell (Taniguchi et 
al., 2002; Acquaviva and Pines, 2006). In late G2 phase Plk1 localises at the 
centrosomes and then becomes enriched at kinetochores in prometaphase and 
metaphase, where it persists throughout most of mitosis (Golsteyn et al., 1995). 
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In anaphase Plk1 localises on the central spindle and finally accumulates on the 
midbody in telophase (Golsteyn et al., 1995). 
 
One of the major functions attributed to Plk1 is promoting mitotic entry. Plk1 
achieves that by promoting Cdk1/cyclin B activation in three ways: (1) It 
phosphorylates and thereby promotes nuclear translocation of Cdc25C, a kinase 
activator of Cdk1/cyclin B (Roshak et al., 2000; Toyoshima-Morimoto et al., 
2002). (2) It phosphorylates and so promotes the degradation of the Cdk1/cyclin 
B-inhibiting kinases Wee1 and Myt1 (Nakajima et al., 2003; Watanabe et al., 
2004). (3) It phosphorylates cyclin B at the centrosome, which is the primary site 
where Cdk1/cyclin B is known to be activated (Toyoshima-Morimoto et al., 
2001; Jackman et al., 2003). However, Plk1 activity has been shown to be non-
essential for mitotic entry as its inhibition does not block mitotic entry, but 
significantly delays it (Lenart et al., 2007). 
 
Plk1 is also involved in centrosome maturation and subsequently the formation 
and elongation of the bipolar spindle.  It has been suggested that Nlp 
phosphorylation by Plk1 leads to dissociation of the former from the 
centrosome, thereby allowing the recruitment of various proteins, most 
importantly γ-tubulin, which are essential for microtubule nucleation 
(Casenghi et al., 2003; Casenghi et al., 2005; Rapley et al., 2005). 
 
Plk1 is also implicated in regulating chromosome alignment on the mitotic 
spindle. A number of studies have shown that Plk1 activity and localisation at 
the kinetochore are required for the formation of Kt-Mt attachments and 
thereby chromosome congression (Casenghi et al., 2003; Sumara et al., 2004; 
Lenart et al., 2007). It has also been observed that Plk1 levels are increased on 
the kinetochores of chromosomes that have not established bipolar attachments 
and are not under tension (Ahonen et al., 2005; Lenart et al., 2007). Plk1 also 
phosphorylates proteins that are involved in the SAC, including BubR1 and 
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Bub1, but these phosphorylations appear to be non-essential for SAC activation 
(Sumara et al., 2004; Burkard et al., 2007; Lenart et al., 2007; Santamaria et al., 
2007). Nonetheless, BubR1 is required for Kt-Mt attachments (Lampson and 
Kapoor, 2005) and its levels of phosphorylation by Plk1 are higher at 
kinetochores that are not under tension (Elowe et al., 2007). 
 
 Plk1 is also involved in direct and indirect activation of the APC/C. Several 
APC/C subunits are phosphorylated by Plk1, including Cdc16, Cdc27, Tsg24 the 
Apc1 subunits (Kotani et al., 1998; Golan et al., 2002; Kraft et al., 2003). Indirect 
activation of the APC/C by Plk1 involves the phosphorylation of the APC/C-
activator Cdk1/cyclin B (Golan et al., 2002), together with the phosphorylation 
of the APC/C-inhibitor Emi1, which promotes its subsequent targeting for 
degradation by the ubiquitin ligase SCFβTrcp1 (Hansen et al., 2004; Moshe et al., 
2004). However, APC/C activation appears to occur even in the absence of Plk1 
activity (Kraft et al., 2003; Lenart et al., 2007). 
 
Cytokinesis is also highly sensitive to Plk1 activity.  Recent studies have shown 
that the onset of cytokinesis in human cells is blocked when Plk1 activity is 
inhibited at the metaphase to anaphase transition (Brennan et al., 2007b; 
Burkard et al., 2007; Petronczki et al., 2007; Santamaria et al., 2007). In particular, 
cells treated with different Plk1 inhibitors failed to form a contractile ring at the 
equatorial cortex during anaphase and to accumulate RhoA, the upstream 
regulator of the contractile function. The reason behind this phenotype 
appeared to be the abolishment of Ect2 recruitment to the spindle midzone, an 
essential activator of the RhoA network linking the anaphase spindle to the 
cellular cortex and stimulating cytokinesis (Brennan et al., 2007b; Burkard et al., 
2007; Petronczki et al., 2007; Santamaria et al., 2007). 
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Finally, as already described in detail in section 1.2.3, Plk1 is involved in the 
removal of cohesin from chromosome arms of sister chromatids prior to 
anaphase (Sumara et al., 2002; Hauf et al., 2005). 
 
Of particular interest is the study by Lenart et al. (Lenart et al., 2007) where the 
authors have used BI 2536, a small-molecule inhibitor of Plk1, to delineate some 
of the known functions of Plk1 in mitosis and uncover novel ones. According to 
this study, treatment of HeLa cells with BI 2536 induces a delay in prophase, 
consistent with a previously reported role for Plk1 in promoting activation of 
Cdk1/Cyclin B (Dehapiot et al., 2013). Once into mitosis, cells were arrested in 
late prophase, due to SAC activation, with abnormal monopolar spindles, 
which could not attach stably to chromosomes. Moreover, consistent with 
previous reports (Hansen et al., 2004; Moshe et al., 2004), BI 2536 inhibited the 
degradation of Emi1. However, cyclin A degradation was not perturbed, 
showing that Emi1 degradation is not required for Cyclin A to be degraded. 
This also shows that the prophase arrest caused by BI 2536 does not depend on 
Cyclin A not being degraded, which has been previously reported to inhibit exit 
from mitosis (den Elzen and Pines, 2001). Another significant observation made 
possible by the use BI 2536 was that Plk1 activity is essential not just for the 
establishment, but also for the maintenance of chromosome biorientation 
(Peters et al., 2006; Lenart et al., 2007). 
 
Studies in mouse oocytes have revealed that Plk1 exhibits a highly dynamic 
localisation pattern also during mammalian meiosis (Fig 1.8). Plk1 is known to 
be activated by phosphorylation shortly prior to GVBD (Pahlavan et al., 2000) 
suggesting it could be involved in promoting meiotic resumption/Cdk1 
activation. Consistent with that, its inhibition either by antibody-microinjection  
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Figure 1.8 Plk1 structure and functions in mitosis and meiosis 
(See legend on next page) 
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Figure 1.8 Plk1 structure and functions in mitosis and meiosis 
(A) Schematic representation of mouse Plk1. The positions of the kinase domain (red) and polo-
boxes 1 and 2 (purple) are depicted. The amino acid (aa) sequences that mediate its nuclear 
localization (green) and its destruction by the proteasome (D-box; yellow) are also shown. The 
amino- and carboxyl- termini are also indicated. Numbers indicate amino acid positions. 
 
(B) Schematic representation of human mitosis indicating PLK1 localisation (green). During 
interphase PLK1 is diffusely distributed throughout the cell (Acquaviva and Pines, 2006). In late 
G2 phase PLK1 localises at the centrosomes and then becomes enriched at kinetochores in 
prometaphase and metaphase, where it persists throughout most of mitosis. In anaphase PLK1 
localises on the central spindle and finally accumulates on the midbody in telophase. Major 
functions of PLK1 are listed in gray boxes (black lettering) at the corresponding cell cycle stages: 
-Recovery after DNA damage: Turns off the DNA damage checkpoint by promoting the 
degradation of Claspin (Prinz et al., 1998; Pfleger and Kirschner, 2000; Barford, 2011). 
-Centrosome maturation: Recruits γ-Tubulin, which is essential for microtubule nucleation 
(Lane and Nigg, 1996; Nasmyth, 2005; Schreiber et al., 2011). 
-Mitotic entry/ Cdk1 activation: Activates Cdc25C, an activator of Cdk1/cyclin B (Toyoshima-
Morimoto et al., 2002; Hershko, 2005). Promotes the degradation of the Cdk1/cyclin B-inhibiting 
kinases Wee1 and Myt1(Watanabe et al., 2004; Baker et al., 2007). Phosphorylates cyclin B at the 
centrosome (Toyoshima-Morimoto et al., 2001; Jackman et al., 2003). 
-APC/C activation: Stimulates APC/C activity by phosphorylating its Apc1, Cdc16, Cdc27 and 
Tsg24 subunits (Kotani et al., 1998; Golan et al., 2002; Kraft et al., 2003). Induces the destruction 
of APC/CCdh1 inhibitor Emi1 (Hansen et al., 2004; Moshe et al., 2004). However, PLK1 activity 
appears to be nonessential for APC/C activation in mitosis (Lenart et al., 2007). 
-Prophase pathway: Removes cohesin from chromosome arms prior to anaphase (Sumara et al., 
2002; Hauf et al., 2005). 
-Chromosome condensation: Involved in DNA supercoiling (Kulukian et al., 2009). Plk1 
inhibition/depletion produces hyper-condensed chromosomes (LeMaire-Adkins et al., 1997; 
Gimenez-Abian et al., 2004; Lenart et al., 2007). 
-Mt-Kt attachment: Promotes the formation of stable Kt-Mt attachments (Lenart et al., 2007), 
thus facilitating chromosome alignment, most probably through phosphorylation of BubR1 (Li 
and Zhang, 2004; Elowe et al., 2007). 
-Spindle elongation: Plk1 inhibition abrogates spindle elongation during anaphase B (Brennan 
et al., 2007a). 
-Cytokinesis: Plk1 activity is essential for the activation of RhoA, the upstream regulator of the 
contractile function (Brennan et al., 2007a; Burkard et al., 2007; Petronczki et al., 2007; Santamaria 
et al., 2007). [B adapted from (Lens et al., 2010)]. 
 
(C) Schematic representation of mouse oocyte meiosis from Prophase I to MetII arrest indicating 
Plk1 localisation (green). In late prophase-arrest Plk1 is diffusely distributed throughout the 
ooplasm and enters the nucleus (GV) shortly prior to GVBD (Hoffmann et al., 2011). In 
prometaphase and metaphase Plk1 becomes enriched at spindle poles and centromeres and also 
associates with spindle Mts. In anaphase Plk1 localises on the central spindle, then at the 
cleavage plane and finally accumulates on the midbody in telophase. During MetII arrest Plk1 
is seen at spindle poles and along spindle Mts (Rieder et al., 1994; Wianny et al., 1998; Pahlavan 
et al., 2000; Hassold and Hunt, 2009). Meiosis-specific functions of Plk1 remain largely elusive 
and are listed in gray boxes (red lettering) at the corresponding cell cycle stages: 
- Cdk1 activation: Plk1 inhibition delays GVBD suggesting it is a positive regulator of meiotic 
resumption (Tong et al., 2002; Vanderheyden et al., 2009). 
-Spindle formation: Plk1 inhibition abrogates spindle formation (Tong et al., 2002). 
-MII resumption: Induces the destruction of APC/CCdc20 inhibitor Emi2 (Madgwick et al.; Lane et 
al., 2012). 
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(Tong et al., 2002) or by chemical means (Vanderheyden et al., 2009) causes a 
delay in GVBD. In budding yeast, the Plk1 homologue, Cdc5, participates in the 
regulation of chromosome segregation during MI by being involved into the 
establishment of correct Kt-Mt attachments and removal of cohesin from 
chromosomes, through phosphorylation of Rec8 (Clyne et al., 2003; Lee and 
Amon, 2003; Brar et al., 2006). A previous study suggested that Plk1 
phosphorylation is essential for Rec8 cleavage by separase in vitro (Kudo et al., 
2009), however, it is yet unknown whether Plk1 regulates these processes in 
mammalian oocytes. 
1.6 Failure of meiotic division and associated repercussions 
The process of cell division is of paramount importance for all organisms, with 
errors in chromosome segregation proving disastrous, either for the organism 
per se or its progeny. In most sexually reproducing species, meiosis is a highly 
accurate process and chromosome missegregation is a rare phenomenon. 
However, in humans more than 20% of all oocytes are regarded as being 
aneuploid, causing infertility, miscarriages and genetic birth defects, such as 
Down syndrome (trisomy 21), Turner syndrome (single X female) and 
Klinefelter’s syndrome (XXY male) (Kuliev et al., 2005; Rosenbusch and 
Schneider, 2006; Pacchierotti et al., 2007). Approximately 2-3% of newborns are 
trisomic (Hassold and Jacobs, 1984) and most aneuploidies are non-viable; 35% 
of spontaneous abortions between 6th and 20th week of gestation and 4% of 
foetal deaths occurring during the second trimester of gestation are a 
consequence of aneuploid conceptions (Jacobs, 1992; Wells and Delhanty, 2000). 
Most of the errors leading to chromosome missegregation and aneuploidy may 
occur predominantly during the extended prophase I arrest of MI (Lister et al.) 
and are associated with the failure to establish, maintain or resolve chiasmata or 
with premature sister chromatid segregation (Jones, 2008). 
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Evidence from clinical genetic studies in cases of trisomy 21 provided valuable 
insight into the predisposition of oocytes to segregation errors during MI. The 
highest risk was associated with an absence of crossovers resulting to 
segregation of univalent rather than bivalent chromosomes. A single crossover 
in the subtelomeric or pericentromeric region was also associated with a high 
risk of trisomy (Lamb et al., 1997). These data gave ground to the idea that 
bivalents with susceptible chiasmata configurations were predisposed to 
missegregation during MI (Lamb et al., 1996; Lamb et al., 1997; Warren and 
Gorringe, 2006). However, it was later found that this association is lost during 
maternal ageing (Lamb et al., 2005) . This implied that age-related errors in 
female MI are due to defects occurring subsequent to crossover formation. 
Evidence from recent studies (Hodges et al., 2005; Chiang et al., 2010; Lister et 
al., 2010; Revenkova et al., 2010; Tachibana-Konwalski et al., 2010) has 
established cohesin deficiency as a leading candidate for such a defect. 
 
Although it had been known since the early 1930’s that the occurrence of Down 
syndrome increases with maternal age (Penrose, 2009), it was only in the late 
80’s that the exact correlation between them was established (Morton et al., 
1988). Today we know that the probability of a pregnancy involving a trisomic 
fetus increases abruptly in women around the age of thirty-seven years old 
(Hassold and Hunt, 2001). Apart from this increasing risk, another thing that 
comes with ageing is a decrease in the chances of establishing a successful 
pregnancy due to the lack of oocytes. Maternal fecundity has a limit in time, 
with ovarian reserves being constantly reduced until the onset of menopause 
(Telfer and McLaughlin, 2007). The impact of this decline in oocyte numbers 
becomes more daunting when we consider the fact that instead of being stable 
it gradually accelerates at mid-thirties (Faddy et al., 1992; Faddy, 2000). 
However, the reason why chromosomal instability becomes more prevalent as 
we reach the end of the oocyte pool remains unclear. 
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In the last fifty years birth patterns have markedly changed in developed 
societies. A variety of socioeconomic factors, influence contemporary human 
reproductive culture and ideology and as a result couples seek to have fewer 
children and they have them at older ages than before. For example, in the UK, 
between 1985 and 2001 there was a doubling (from 8% to 16%) in the number of 
first births for parents over the age of 35 years old (Rai and Regan, 2006). This 
trend to postpone childbirth combined with the increased risk of aneuploidies 
as women get older, have amplified the numbers of miscarriages and 
pregnancy terminations in recent years. As a reaction to these circumstances, 
there is an increasing focus on research in the field of female reproductive 
ageing.  Not surprisingly, very little is still known about the molecular basis of 
this phenomenon in humans, a good reason being the ethical and physical 
limitations associated with human oocyte and embryo research. Our research 
employs the appropriate animal models that mimic human female ageing and 
aims to contribute to a further understanding of this inevitable physiological 
process. 
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1.7 Aims 
The overall aim of this thesis is to investigate the mechanism of chromosome 
segregation in female mammalian meiosis in the context of reproductive 
ageing. 
 
The specific aims were: 
1. To further our understanding of female age-related meiotic segregation 
errors, I aim to investigate the effect of ageing on chromosome-associated 
cohesin and its protector Sgo2. 
 
2. To advance knowledge of the mechanisms governing chromosome 
segregation in mammalian oocytes, I will characterise the functions of Plk1 
during progression through MI using the small-molecule inhibitor BI 2536. 
 
3. To establish whether oocyte chromosomal cohesin is removed by a 
mechanism analogous to the Plk1-dependent prophase pathway of somatic 
cells, I will measure the effect of Plk1 inhibition on levels of chromosome-
associated cohesin using the transgenic Rec-Myc mouse strain.  
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 : Materials and Methods Chapter 2
2.1 Mouse Strains 
C57BL/Icrfat mice were obtained from a long-established colony, which had 
been selected for use in studies of intrinsic ageing because it is free from specific 
age-associated pathologies and thus provides a good general model of ageing 
(Rowlatt et al., 1976). Smc1β+/+ and Smc1β-/- female mice were provided by Rolf 
Jessberger and their generation has been previously described (Revenkova et al., 
2004). The transgenic Rec8-Myc mouse strain was provided by Nobuaki Kudo 
and its generation has also been described previously (Kudo et al., 2009). 
Finally, CD1 mice have also been used. The research was licensed by the UK 
Home Office. 
2.2 Harvest, culture and drug treatment of mouse oocytes 
Eight to twelve weeks old female CD1, eight to twelve weeks old female 
Smc1β+/+ and Smc1β-/-, eight to twelve weeks old and twelve month old Rec8-
myc, and two month and fourteen month old C57BL/Icfrat mice were killed by 
cervical dislocation and had their ovaries dissected out and briefly held in pre-
warmed M2 medium (Sigma Aldrich, UK). C57BL/Icfrat mice were injected 
with 7.5IU of pregnant mare serum gonadotrophin (PMSG; Sigma Aldrich, UK) 
approximately 48 hours prior to ovary collection. Oocytes were released from 
the excised ovaries by puncturing follicles with an insulin needle on a 
microscope stage in pre-warmed M2 medium supplemented with 0.022μg/ml 3-
isobutyl-1-methylxanthine (IBMX; Sigma Aldrich, UK) to maintain oocytes at 
the germinal vesicle stage. After collection, only mature oocytes with a central 
GV were isolated for further experimentation and stored in 40μl droplets of 
pre-warmed M2 supplemented with IBMX overlaid with mineral oil (Sigma 
Aldrich, UK), until further use. Oocytes with peripheral GV were either 
discarded or used for optimising experimental techniques.  
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Oocytes to be in vitro matured were “washed” and transferred to 40μl drops of 
pre-equilibrated G-IVF™ medium (Vitrolife, Sweden), overlaid with pre-
equilibrated mineral oil and incubated at 37oC in a humidified 7% CO2 
environment. In the absence of IBMX, MI resumption would occur, which is 
marked by GVBD. In order to be able to make timed and synchronous 
observations, the oocytes were scored for GVBD at 1, 1.5 and 2 hours after 
transfer to G-IVF, separated into groups accordingly and allowed to mature to 
the desired stage. Oocytes that had not undergone GVBD within 2 hours of G-
IVF incubation were either discarded or used for optimising experimental 
methods. 
 
Depending on the purpose of the experiment the “control” in vitro maturation 
medium would be either neat G-IVF or G-IVF supplemented with 1:500 (v/v) 
DMSO (Sigma Aldrich, UK).  
The Plk1 inhibitor BI 2536 (Axon Medchem, The Netherlands) was 
reconstituted to a 5M solution in DMSO (as recommended by the 
manufacturer) and then diluted down and aliquoted to individual 1.5μM, 2μM, 
3.125μM, 6.25μM and 12.5μM working solutions, which were stored at -20oC. 
To supplement G-IVF with IBMX, 1μl of the appropriate working solution was 
added to 500μl of G-IVF. 
Nocodazole (Sigma Aldrich, UK) was reconstituted in a 5mg/ml solution in 
DMSO and stored at -20oC. Nocodazole treatments were carried out using G-
IVF supplemented with 10μg/ml nocodazole, which allows the formation of the 
spindle assembly but causes microtubule instability, thus preventing 
chromosome congression and alignment. 
2.3 Isolation of Oocytes from Pre-antral Follicles 
Following puncture of antral follicles from excised ovaries, the remaining 
ovarian tissue was centrifuged at 700 rpm for 5 min. The supernatant was 
discarded and the pellet was washed twice in PBS pre-warmed at 37oC. After 
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the final wash, the pellet was resuspended in 4ml of 0.5 mg/ml collagenase type 
IV (Worthington Biochemical Corp., USA) and 2 IU TURBO™ DNase 
(Invitrogen, UK) in PBS and incubated at 37oC for 30-60min, on a shaker with 
occasional pipetting. Oocytes were manually isolated and transferred to M2 
medium supplemented with 0.022 μg/ml IBMX. 
2.4 Microinjection 
Microinjections were performed on a Nikon TE-300 inverted diaphot 
microscope, fitted with an MMN-1 micromanipulator (Narishige, Japan) and an 
IM-300 Motor-Drive Microinjector (Narishige, Japan). Injection needles were 
made from thin-wall borosilicate glass capillaries with filament (BF 100-50-10; 
Intracel, UK) using a P-97 micropipette puller (Sutter Instruments Co, USA) 
programmed with the following settings: pressure, 200; heat, 518; pull, 70; 
velocity, 70; time, 150. Injection needle tips were angled to approximately 30° 
using a microforge device (Research Instruments, UK). 
 
For mRNA microinjections, stock in vitro-transcribed mRNA was diluted to 500-
1000ng/μl with injection buffer and 1.5μl of mRNA solution was loaded into a 
shortened glass capillary and mounted on a glass slide using beeswax. The 
glass slide with the capillary containing mRNA was placed on the microscope 
stage and the injection needle tip was broken open by gently tapping it to the 
edge of the glass capillary. The injection needle was then inserted into the 
mRNA solution and a negative pressure was applied to allow loading. mRNA 
loading columns were kept at 4oC during experiments, to avoid evaporation in 
case re-loading was required. 
 
Mature GV stage oocytes to be microinjected were transferred to appropriate 
culture dishes containing 5μl droplets of IBMX-supplemented M2 medium, 
covered with mineral oil.  Five to ten oocytes were transferred in each droplet 
and the dishes were kept at 37oC.  During microinjections, the oocytes were 
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immobilised by gentle suction using a holding pipette (Hunter Scientific, UK) 
and the injection needle was inserted through the zona pellucida and oolemma, 
into the ooplasm, taking care to avoid the GV. Injections producing a 
cytoplasmic disturbance of approximately the size of the GV (~5% of oocyte 
volume) were administered. Injection pressure and balance pressure had to be 
adjusted constantly throughout a microinjection session to avoid intake of 
culture medium and deliver equal injection volumes. Following injections, 
oocytes were allowed to recover for 1-2 hours at 37oC, before being used for 
further experimentation. 
2.5 Oocyte immuno-fluorescence staining 
2.5.1 Whole oocyte Ca2+-buffer treatment and fixation 
Maturing oocytes were collected from in vitro culture and washed with pre-
warmed PBS at 37oC. Oocytes were then transferred in a drop of pre-warmed 
Ca2+-buffer for 90 sec on a stage heated at 37oC. Following Ca2 treatment, 
oocytes were fixed in Ca2+-buffer supplemented with 1% formaldehyde for 30 
min at room temperature. After fixation, the oocytes were washed three times 
(5min/wash) with PBT (PBS supplemented with 0.1% Triton X-100) and were 
stored in PBS at 4oC for a maximum of three weeks. 
2.5.2 Indirect immuno-fluorescence staining of whole oocytes 
Fixed oocytes were blocked with 4% BSA in PBT (block solution) overnight at 
4oC or for 1h at room temperature. Primary antibody incubations were 
performed in block solution overnight at 4oC, using the antibodies and the 
concentrations shown in table 2.1. After washing three times 
(5min/10min/10min) in PBT, the oocytes were incubated with the appropriate 
secondary antibodies (shown in table 2.1) diluted in block solution, in dark at 
room temperature for 1h on a shaker at a very low rpm setting.  After washing 
three times (10min/15min/20min) in PBT and once (2min) in PBS, the oocytes 
were transferred into droplets of Vectashield with DAPI (Vector Labs, UK) 
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diluted 1:10 with PBS, in glass bottom dishes, and covered with mineral oil. 
Imaging was performed as described in section 2.9.3. 
 
Primary 
Antibody 
Source Dilution 
Secondary 
Antobody 
Source Dilution 
human 
AutoAb CREST 
Cellon 
HCT-0100 
1:50 
goat-anti-
human Cy5 
Jackson 
Immuno 
109-175-003 
1:400 
human 
AutoAb CREST 
Europa Bioproducts 
FZ90C-CS1058 
1:100 
goat-anti-
human Cy5 
or 
goat-anti-
human 
AlexaFluor 555 
Jackson 
Immuno 
109-175-003 
or 
Invitrogen 
A-21433 
1:400 
or 
1:800 
rabbit-anti-
human 
Sgo2 
Gift from Yoshinori 
Watanabe, The 
University of Tokyo, 
Tokyo 
1:50 
donkey-anti-
rabbit 
AlexaFluor 488 
Invitrogen 
A-21206 
1:800 
mouse-anti 
Myc Tag 
clone 4A6 
Millipore 
05-724 
1:100 
goat-anti-
mouse 
AlexaFluor 488 
Invitrogen 
A-11001 
1:800 
mouse-anti-
PP2A 
monoclonal 
clone 106 
Millipore 
05-421 
1:50 
donkey-anti-
mouse 
AlexaFluor 555 
A-31570 1:800 
mouse-anti Plk1 
monoclonal 
clone F-8 
Santa Cruz 
17783 
1:100 
goat-anti-
mouse 
AlexaFluor 488 
Invitrogen 
A-11001 
1:800 
mouse-anti-a-
Tubulin 
(DM1A) 
Sigma Aldrich 
T6199 
1:100 
goat-anti-
mouse 
AlexaFluor 488 
Invitrogen 
A-11001 
1:800 
Table 2.1 Antibodies used for immunofluorescence staining 
2.6 Chromosome Spreads that preserve chromosome-associated proteins 
The protocol for chromosome spreads was modified from Patricia Hunt (Scott, 
2009). 
2.6.1 Paraformaldehyde and slide preparation 
0.25g of paraformaldehyde (PFA) and 4μl of 10M NaOH were added in 22.5ml 
of Milli-Q H2O (Millipore, UK) in a 50ml universal tube. The solution was 
incubated at 60°C with occasional vortexing until it turned clear. Once cooled to 
room temperature pH was adjusted to 9.2 using 50mM boric acid. Finally, 175μl 
of 20% (v/v) Triton X-100 and 150μl of 0.5M DTT were added shortly prior to 
use. 
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In order to have a reference point that would assist in locating the chromosome 
spreads, a line was drawn on the back of the poly-L-Lysine coated glass 
microscope slides (Polysine® Slides; Fisher Scientific, UK) to be used, using a 
permanent marker.  
2.6.2 Removal of zona pellucida, fixation and spreading 
The zona pellucida was dissolved by brief exposure to a drop of acid Tyrode’s 
solution pre-warmed at 37oC. The oocytes were then moved through two 
successive drops of M2 medium, also pre-warmed at 37oC, to remove Tyrode’s 
solution, and were then incubated for 2 minutes in a drop of hypotonic 0.5% 
(w/v) solution of tri-sodium citrate. While waiting for the incubation, a slide 
was dipped in the PFA solution and excess fixative was removed by gentle 
tapping in a paper towel. The oocytes were then transferred on the slide, along 
the length of the drawn line under an SMZ-2T (Nikon, Japan) stereomicroscope. 
Finally, the slide was placed inside a humid chamber and allowed to dry 
overnight at room temperature. 
 
Following overnight incubation, a rectangular region was drawn around the 
area containing the spreads using an ImmEdge™ hydrophobic barrier pen 
(Vector Laboratories, UK), to create a “chamber” to hold media drops for 
subsequent immunostaining procedures. After drying, slides were washed 
twice (2x2min) in 0.4% (v/v) Kodak Photo-Flo (Silverprint, UK) in dH2O 
solution, then twice (2x2min) in PBS and they were finally stored in PBS at 4oC, 
until further use. 
2.6.3 Indirect immunofluorescence staining of chromosome spreads 
Slides containing chromosome spreads were blocked in either 10% (v/v) goat 
serum (Sigma Aldrich, UK) in PBTT (0.1% Triton-X and Tween in PBS) or 10% 
(v/v) donkey serum (Sigma Aldrich, UK) in PBTT, depending in which animal 
the secondary antibodies to be used were raised in (i.e. if secondary antibodies 
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were raised in goat, then the goat block was used). After 1 hour of blocking at 
room temperature, primary antibody incubations were performed in block 
solution overnight at 4oC, using the antibodies and the concentrations shown in 
table 2.1. Following incubation with primary antibody slides were washed as 
follows: once (1x10min) in 0.4% (v/v) Photo-Flo in PBS; twice (2x10min) in 
0.01% (v/v) Triton-X in PBS; once (1x10min) 0.4% (v/v) Photo-Flo in PBS; once 
(1x2min) in PBS. All washes were performed at RT on a shaker at 100rpm. The 
Spreads were then incubated with the appropriate secondary antibodies 
(shown in table 2.1) diluted in block solution, in dark at room temperature for 
1h, before repeating the aforementioned wash steps. Chromosome spreads 
were covered using Vectashield with DAPI and glass coverslips (#1.5; VWR 
International, UK), and sealed with rubber solution to prevent evaporation 
(Halfords, UK). Imaging was performed as described in section 2.9.2. 
2.7 Fluorescent Constructs 
All constructs used in this thesis were manufactured by Lisa Lister or were gifts 
from collaborators. 
 
For the generation of constructs and the production of mRNA the pRN3 vector 
was used (Fig 2.1) (Lemaire et al., 1995). The coding sequence for a fluorescent 
protein was inserted between the cloning site for the gene of interest and the 3’-
UTR for most fluorescent constructs used. The gene of interest was either sub-
cloned or amplified using a polymerase chain reaction (PCR) from a mouse 
oocyte cDNA library, constructed using the SMART PCR cDNA Synthesis Kit 
(Clontech, USA), and inserted into the plasmid by restriction digest and 
ligation.  The cloning was confirmed by sequencing (The Sequencing Service, 
Dundee). 
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Figure 2.3 Conserved domains and motifs of Cdc20 
 
Figure 2.1 Schematic representation of the constructs made using a pRN3 
vector backbone 
The pRN3 vector contains a T3 promoter, an upstream 5 globin untranslated region (UTR), 
which conferees stability of RNA transcripts and a downstream globin 3 UTR and a poly-A 
encoding sequence, to enhance translation. A series of restriction sites (red lines) allow the 
insertion of the desired gene and fluorescent protein coding sequences. The ampicillin 
resistance insert allows the identification of successfully transfected microbial colonies. 
Figure 2.2 Conserved domains and motifs of Cdc20 
A schematic representation of human wild-type Cdc20. Cdc20 contains a C-box, required to 
interact with APC/C core subunits (Schwab et al., 2001; Thornton et al., 2006); a KEN-box, a 
degradation motif (Pfleger and Kirschner, 2000); the Mad2-binding motif (Zhang and Lees, 
2001); a CRY-box, another degradation motif (Reis et al., 2006b); seven WD40 repeats, forming 
a scaffold for protein-protein interactions [reviewed in (Yu, 2007)]; an IR motif at the C-
terminal, which contributes to binding to the core APC/C subunits, as well as to its activity 
(Passmore et al., 2003; Vodermaier et al., 2003; Thornton et al., 2006). The R132A mutation 
allows robust binding to APC/C, but reduces the binding to Mad2 (Zhang and Lees, 2001; Ge 
et al., 2009). 
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2.8 Preparation of mRNAs 
Capped mRNA constructs with a 30 poly-A tail were made using an 
mMESSAGE mMACHINE kit (T3, T7, or SP6 kit, depending on the RNA 
polymerase promoter site on the plasmid; Ambion, UK) from plasmid cDNA 
encoding histone H2B-RFP (a gift from Z. Polanski), cyclin B1-GFP (a gift from 
M. Levasseur), securin-YFP (a gift from K. Wassmann), Cdc20WT (a gift from A. 
Rattani) and Cdc20R132A (a gift from A. Rattani; Fig 2.2). 
 
2.9 Microscopic Methods 
2.9.1 Time-lapse (4D) Microscopy 
Oocytes injected with fluorescent mRNA constructs (as described in 2.4) were 
transferred into a drop of pre-equilibrated G-IVF, covered with mineral oil, in a 
glass bottom dish (Ibidi μ-Dish; Thistle Scientific, UK). In experiments 
involving the use of BI 2536, a 40μl drop was made, as it was observed that 
smaller volumes (e.g. 2μl, as in controls) would weaken the effect of the 
inhibitor, probably because the latter is moderately oil soluble. The dish was 
fitted in a custom made CO2 chamber (Medical Physics Department, Newcastle 
University) which was securely placed on the microscope stage and would 
allow imaging while maintaining a 7% CO2 atmosphere. 
 
Time-lapse imaging was performed on a Nikon Eclipse TE-2000-U inverted 
microscope using a 20x/0.75 n.a. Plan Fluor oil immersion objective and a 
Photometrics Cool- SnapHQ interline cooled charge-coupled device (CCD) 
camera (Roper Scientific, USA). The microscope was fitted with an incubator 
(Solent, UK) to maintain a stable temperature of 37oC. For fluorescence imaging, 
illumination was provided by a Xenon short arc XBO® 100W OFR lamp (Osram, 
Germany) and the following filter settings (Chroma, Germany) were available: 
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Fluorescent Taq / Stain 
Excitation 
Filter 
Dichroic 
Emission 
Filter 
DAPI 355±25 400 
420 
Longpass 
GFP/AlexaFluor 488 480±10 500 510±10 
YFP 500±10 
CYR 
Multi 
Bandpass 
535±15 
RFP 580±10 
GFP/RFP 
Multi 
Bandpass 
630±30 
Rhodamine/AlexaFluor 
555 
535±25 565 
590 
Longpass 
Cy5 620±30 660 700±37 
 
Filter wheels, shutters, Z-focus motor (Prior Scientific, UK) and camera were 
driven by Metamorph Image Acquisition software (Universal Imaging, USA) 
via a ProScan™ Controller (Prior Scientific, UK). 
 
Oocytes were imaged for 14–16 hours with bright-field or DIC and fluorescence 
images acquired every 20 min on 5 x 0.75 μm Z planes. 
2.9.2 Epifluorescence Imaging of Chromosome Spreads 
The microscope used for time-lapse imaging was also utilised for acquisition of 
fluorescence images of chromosome spreads, prepared as described in 2.6.3, 
using a 100x/1.3 n.a Plan Fluor oil immersion objective. 
 
IF stained chromosome spreads were also imaged on a Zeiss Axio Imager Z1 
microscope fitted with a Zeiss ApoTome 2. Images were captured using an EC 
Plan Apochromat 63x/1.4 Oil DIC objective and a Zeiss AxioCam HRm Rev3 
camera in combination with the Axiovision 4.8 software package. Excitation 
source was a Mercury short arc HBO® 100 W/2 lamp (Osram, Germany).  
The filter sets that were utilised were: 
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Filter 
Number 
Fluorophore 
Excitation 
Filter (nm) 
Dichroic 
Mirror cut off 
(nm) 
Emission 
Filter (nm) 
Zeiss 49 DAPI 335-385 395 420-470 
Zeiss 38HE Alexa 488 450-490 495 500-550 
Zeiss 20HE 
Alexa 555 
Rhodamine 
534-558 560 567-647 
Zeiss 50 Cy5 610-670 660 665-715 
 
Image acquisition of mature GV-stage and immature pre-antral-follicle oocytes, 
described in 3.2, was performed by Anna Kouznetsova, on a Leica DMRXA 
microscope equipped with a Hamamatsu C4880-40 CCD camera. 
2.9.3 Confocal Imaging 
Oocytes prepared as described in 2.5 were imaged using a Nikon A1R confocal 
microscope, using a Plan Apo VC 100x/1.40 Oil DIC N2 objective. Sequential 
(Channel series ON)/Simultaneous (Channel series OFF) excitation at 405nm, 
488nm, 561nm and 642nm was provided by the 405nm Cube Laser (Coherent 
Inc., USA), 488nm Argon Laser (Melles Griot, USA), Sapphire 561nm Laser 
(Coherent Inc., USA) and Red Diode 642nm Laser (Melles Griot, USA), 
respectively. 
Emission filters BP 425-475nm, BP 525-555nm, 570-620nm and 662-737nm were 
used to collect DAPI, Alexa 488, Alexa 555 and Cy5 signal respectively. 
Images, with a frame size of 1024x1024 pixels and a 2x line average, were 
captured using the Nikon Elements AR software package. The entire spindle 
was imaged with Z-confocal sections every 0.5 μm, in total covering at least 
15.91μm x 15.91μm x 12.5μm volume. 
 
2.10 Image Processing and Quantification 
All figures and images in this thesis were designed and produced using Adobe 
Photoshop (Adobe Systems), Adobe Illustrator (Adobe Systems) and 
PowerPoint (Microsoft), unless otherwise indicated. 
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2.10.1 Time-lapse 
Processing and analysis of time-lapse acquisitions was performed using 
MetaMorph software. Best focus images were identified for each timepoint and 
used for further analysis. To analyse the dynamics of a particular fluorophore, a 
region of interest has been drawn inside the oocyte and the average 
fluorescence intensity (FI) minus background FI was measured at each 
timepoint. The values were normalised relative to that of GVBD and were 
plotted against time in Excel (Microsoft). 
 
2.10.2 Chromosome spreads 
Images were acquired as raw 12-bit (Zeis Axio Imager) or 16-bit (Nikon Eclipse) 
images using identical exposure times within each experiment. Pseudo-
colouring, brightness/contrast adjustments and general image processing were 
done using ImageJ software (http://rsb.info.nih.gov/ij/). For quantification of 
antibody staining fluorescence intensities (FI), six to eight cells or chromosome 
spreads were randomly selected. Prior to quantification, background 
subtraction was performed using the “subtract background” function in ImageJ, 
which removes uneven background from images using a “rolling ball” 
algorithm (Sternberg, 1983). In order to determine the appropriate “rolling ball 
radius”, different settings were used and average CREST FI of individual 
centromeres was measured at each setting. Then average CREST FI of the same 
centromeres was measured again, but this time local background was 
subtracted using the method described by Hoffman et al. (Hoffman et al., 2001). 
Briefly, an “inner” square region of interest (ROI) was drawn manually around 
a centromere and integrated FI was measured using MetaMorph software. This 
ROI was then expanded to create an “outer” region. The integrated FI of the 
“outer” ROI was subtracted from the “inner” ROI, after scaling values for 
differences in area, as described previously (Hoffman et al., 2001; Waters, 2009). 
Finally, the background-subtracted CREST integrated FI was divided by the 
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area of the “inner” ROI. The average CREST FI values obtained by utilizing the 
two different methods were statistically compared in Excel and the “rolling ball 
radius” setting that gave a correlation coefficient of approximately 1 (R2= 
0.9895) was chosen for further application. For calculating centromeric 
Rec8:CREST fluorescence intensity ratios (Fig 5.4), following background FI 
subtraction, a square region of fixed  area was centered on the centromere to be 
measured and the Rec8 and CREST intensities were measured in the same 
region. 
 
3D surface plots of FI were produced using the “Interactive 3D Surface plot” 
plug-in in ImageJ (Barthel K.U.; Internationale Medieninformatik 
Berlin, Germany). 
 
Inter-centromere distances were measured as described in 4.5.1. Briefly, 
“linear” ROI were drawn manually through sister-centromere CREST foci and 
their FI/length profiles were measured and logged using the “Plot Profile” 
function in ImageJ. Inter-centromeric distance (Δx) values were calculated using 
the in-house developed software Extrema™ (Glenis V.; School of civil 
engineering and geosciences, Newcastle University). 
2.10.3 Confocal 
With confocal images the “background subtraction” function of the Nikon 
Elements AR software was used to optimise image quality.  3D rendering of Z-
stacks and subsequent distance measurements were performed using Nikon 
Elements AR software. Z-projections of maximum intensity and general image 
processing were done using ImageJ software. 
 
2.11 Statistical Analysis 
All statistical calculations and relevant data plotting were performed using 
Minitab (Minitab Inc., USA) or GraphPad Prism (GraphPad Software, Inc., 
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USA) software. For numerical values the normality of the distribution of the 
data was firstly assessed using the either the Kolgomorov-Smirnov test or the 
D’Agostino and Pearson omnibus normality test. When normal distribution 
was confirmed, the appropriate parametric test was carried out. If normality 
was rejected, the appropriate non-parametric tests were performed. 
 
The most commonly used tests for parametric data in this thesis were the 
unpaired t-test and one-way Anova, followed by a post hoc Tukey's multiple 
comparison test. The most commonly used non-parametric tests were the Mann 
Whitney test and the Kruskal-Wallis test, followed by a post hoc Dunn's 
multiple comparison test. In case a different test was used it will be specified 
alongside the relevant group of data throughout this thesis. 
 
2.12 Reagents 
All chemicals mentioned in this chapter were purchased from Sigma unless 
otherwise specified. 
 
Ca2+-buffer: 100mM PIPES pH 7.0, 1mM MgCl2, 0.1mM CaCl2, 0.1% Triton X-100 
Tyrode’s solution: 0.8g NaCl, 0.02g KCl, 0.024g CaCl2.2H2O, 0.01g MgCl2.6H2O, 
0.1g Glucose, 0.4g Polyvinylpyrrolidone. Added to 100ml 
Milli-Q water and pH adjusted to 2.5 with 5M HCl 
 Aliquoted and stored at -20°C. 
0.5M DTT: 77.1g/ml DTT in Milli-Q water. Aliquoted and stored at -20°C 
50mM Boric Acid: 0.15g in 50ml of Milli-Q water 
0.5% tri-Sodium Citrate: 0.25g Na3C6H5O7 in 50ml Milli-Q water 
PBS: Diluted from 10x to 1x with Milli-Q water 
Injection Buffer: 1M Tris HCl pH 7.5, 1M KCL in sterile Milli-Q water 
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 . The effect of female ageing on chromosomal Chapter 3
cohesin in oocytes 
3.1 Introduction 
In mammals, cohesion is established during the S-phase in the foetal ovary and 
its resolution to allow chromosome segregation may actually take place months 
(e.g. in mice) or even decades (e.g. in humans) later. This prolonged meiotic 
arrest, combined with the early establishment of cohesion has given rise to the 
notion that the maternal ageing effect could be caused by a gradual depletion of 
cohesin levels.  Initial key findings came from Drosophila melanogaster, where 
age-related meiotic nondisjunction errors in oocytes were associated with 
defects in cohesion (Jeffreys et al., 2003). Since then, various groups including 
ours have studied a variety of mouse models and have provided evidence that 
depletion of cohesin during ageing can lead to chromosome missegregation and 
aneuploidy (Hodges et al., 2005; Liu and Keefe, 2008; Chiang et al., 2010; Lister et 
al., 2010).   
 
The experiments described in this chapter involve the use of oocytes from 
C57BL/Icfrat mice, unless otherwise stated. Previous research in our lab has 
established that the C57BL/Icfrat mouse strain exhibits a distinct maternal age 
effect with aged oocytes appearing to have lower levels of chromosome-
associated cohesin that younger ones. In particular, oocytes from 14-month-old 
mice exhibited a clear depletion of cohesin on chromosome arms and at 
centromeres when compared to 2-month-old oocytes at late prometaphase I 
(Lister et al., 2010). However, given that female ageing is characterised by a 
prolonged prophase arrest, a key question is whether cohesin depletion occurs 
during this prophase arrest. Here, the experiments aiming to answer this 
question are described.  
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3.2 Cohesin is depleted in oocytes of aged mice 
In order to determine whether cohesin is depleted during the extended 
prophase arrest, I have compared the levels of the cohesin subunit Rec8 in the 
nuclei of GV-stage oocytes from 2-month and 14-month-aged mice using 
immunofluorescence (IF) labelling.  Fully grown GV-stage oocytes from pre-
ovulatory follicles were isolated, spread on PFA-coated slides and stained for 
Rec8 and CREST. The results show reduction of cohesin levels in oocytes of 
aged mice (Fig 3.1.A). These results tempted us to investigate even earlier 
stages of oocyte maturation. Therefore, oocytes from pre-antral follicles were 
isolated and similarly spread and stained (Staining and image acquisition was 
performed by Anna Kouznetsova). As with fully-grown GV-stage oocytes, 
cohesin levels were reduced in immature oocytes of aged mice, showing that 
cohesin depletion may occur at all the stages of oocyte development (Fig 3.1.B). 
These findings indicate that cohesin depletion during the protracted prophase 
arrest of aged oocytes may be a major causative factor in age-related 
chromosome missegregation during anaphase I of meiosis.  
 
3.3 Cohesin depletion in aged oocytes is linked with disruption of bivalent 
chromosome structure 
In previous immunofluorescence staining experiments we noticed from the 
CREST staining that sister centromeres are further apart during late 
prometaphase of MI (GVBD+5hr) in oocytes from 14-month-aged mice 
compared to oocytes from 2-month-old mice. This observation prompted a 
more detailed examination aiming to characterise and quantify these variations 
in sister-centromere apposition. 
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Figure 3.1 Cohesin depletion in oocytes of aged mice. 
 
(A) Representative images showing DNA, Rec8, and CREST immunofluorescence (IF) staining 
in the nuclei of a fully-grown GV oocyte from 2-month-old (n = 18 oocytes from three mice) and 
14-month-old (n = 16 from six mice) mice. Scale bar represents 10μm. Corresponding 3D surface 
plots show higher Rec8 fluorescence intensity in the 2-month-old compared with 14-month-old 
GV oocytes. (B) Images show DNA, Rec8, and CREST IF staining in the nuclei of oocytes 
isolated from pre-antral follicles, from 2-month-old (n = 21 from three mice) and 14-month-old 
(n = 12 from six mice) mice. Scale bar represents 10μm. Corresponding 3D surface plots show 
higher Rec8 pixel fluorescence intensity in the 2-month-old compared to 14-month- old oocytes. 
This experiment was performed in collaboration with Anna Kouznetsova. 
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Oocytes from young and old mice were used to prepare chromosome spreads at 
late prometaphase of MI (GVBD+5hr) and stained for CREST (Chromosome 
spreads were prepared by Lisa Lister). CREST antiserum binds to the 
centromeric proteins CENP-A, CENP-B and CENP-C (Earnshaw and Cooke, 
1989) and subsequent staining with a secondary fluorescent probe produces 
clearly visible and well-defined centromere foci. Sister centromeres were 
categorized into three groups; sister centromeres that almost overlap each other 
and appear as single foci, others that are slightly separated and show as 
adjacent foci and finally some that appear as two well separated foci (Fig 3.2.A). 
Classification of numerous sister centromere pairs showed that there were 
significant (P<0.001) differences between young and old mice in all three sister 
centromere configurations (Fig. 3.2.B), with inter-centromere distance 
increasing with age. For example, in young oocytes 90% of MI centromeres 
appeared as “unified”, whereas the respective proportion in old oocytes was 
just 32%. 
 
In order to eliminate any bias that might have entered the sister centromere 
classification analysis, I have also measured the distances between sister 
centromeres. Distances were measured from the outer extremities of the pairs, 
because sister centromeres were often overlapping. Consistent with our 
previous observation, I have found that inter-centromere distances significantly 
(P<0.001) increased in old oocytes compared to young oocytes (Fig 3.2.C). Based 
on these results it could be argued that weakened centromeric cohesion results 
in loss of the tightly apposed structure of sister centromeres required to 
promote monopolar attachment of sister centromeres (Hauf and Watanabe, 
2004). This is consistent with the finding that monopolar attachment in fission 
yeast requires Rec8 at the core centromere (Yokobayashi and Watanabe, 2005).  
Thus, it could be proposed that depletion of cohesin at centromeres creates a 
bias against monopolar attachment by inducing splitting of sister centromeres. 
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Figure 3.2 Reduced cohesin is associated with splitting of sister centromeres 
 
(A) Representative images of sister centromeres at late prometaphase of M I (GVBD+5h) stained 
with CREST appearing as unified, adjacent and separated foci. Crest foci surrounded by white 
boxes are shown in the enlarged images. (B) Graph shows the proportions of centromeres in 2-
month-old (n = 360 centromeres; 10 oocytes from four mice) and 14-month-old (n = 293 
centromeres; 8 oocytes from six mice) oocytes showing unified, adjacent, and separated sister 
centromeres. The proportion of unified sister centromeres was significantly (P < 0.001) reduced 
in 14-month-old oocytes, whereas the proportion of adjacent and separated foci was 
significantly (P < 0.001) higher compared to 2-month-old oocytes. (C) Graph shows the distance 
between the outer extremities of CREST signals in 2-month-old (n = 218 centromeres; 10 oocytes 
from one mouse), and 14-month-old (n = 199 centromeres; nine oocytes from four mice) oocytes. 
The distance was significantly higher in the 14-month-old compared oocytes (P < 0.001). The 
calibrated pixel size for the microscope objective is 66.89 nm. This experiment was performed in 
collaboration with Lisa Lister. 
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3.4 Mechanisms of cohesin depletion and the role of Sgo2 
During anaphase I, cohesin is removed from chromosome arms by separase-
mediated cleavage, which is activated by the APC/C pathway (Buonomo et al., 
2000; Kudo et al., 2006). Throughout this process, centromeric cohesin is 
protected from cleavage by shugoshin (Sgo1 in yeast and Sgo2 in mice) 
(Kitajima et al., 2004). Sgo2 together with PP2A protects centromeric cohesin 
throughout anaphase I until metaphase II, thus allowing proper bivalent 
segregation to occur (Riedel et al., 2006; Lee et al., 2008). Upon fertilization and 
release into anaphase II, centromeric cohesin is removed by separase allowing 
sister chromatid segregation to occur. 
 
Having established that Rec8 is significantly depleted in aged MI oocytes the 
next question was whether this might be the result of a “defective” shugoshin 
protection mechanism. In particular, we decided to focus on Sgo2, which is 
known to protect centromeric cohesion in mouse oocytes during anaphase I 
(Llano et al., 2008) and investigate for differences in its levels between young 
and aged mice.  
3.4.1 Sgo2 levels are reduced in aged mouse oocytes 
Mature oocytes from 2-month and 14-month old mice were harvested at the GV 
stage and were allowed to undergo MI. Chromosome spreads were produced at 
late prometaphase (GVBD+5h) and chromosome-associated Sgo2 and CREST 
were detected by immunofluorescence (IF) (Chromosome spreads were 
prepared by Lisa Lister). Subsequent fluorescence analysis showed that Sgo2 
levels were reduced on chromosomes of older oocytes (Fig 3.3.A/B).  
Interestingly, we found that Sgo2 localises to chromosome arms in young 
oocytes during prometaphase of MI (Fig 3.3A). As this had not been previously 
reported, we confirmed specificity of arm staining by performing siRNA-
mediated depletion of Sgo2 (Lister et al., 2010). Recruitment of Sgo2 to 
chromosome arms as well as centromeres raises the possibility that Sgo2 also 
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functions to protect arm cohesin until the onset of anaphase I.  In support of 
this, data from our lab also indicates that Sgo2 recruits the phosphatase PP2A to 
arms as well as to centromeres (Lisa Lister, PhD thesis).  These results suggest 
that Sgo2 might protect cohesin even before the onset of anaphase I in mouse 
oocytes. 
 
 
Figure 3.3 Age-related decline in chromosome-associated Sgo2 levels 
(A) Representative images of chromosome spreads of oocytes at late prometaphase of MI 
(GVBD+5h) from 2-month-old mice (n = 20 from three mice) and 14-month-old mice (n = 10 
from four mice) stained (IF) for Sgo2 and CREST. Sgo2 levels on chromosomes of oocytes from 
14-month-old mice appear reduced. Chromosomes surrounded by white boxes are shown in the 
enlarged images.  Scale bar represents 10 μm. (B) 3D surface plots of images in (A) showing 
higher Sgo2 fluorescence intensity on chromosomes of 2-month-old compared to 14-month-old 
oocytes. This experiment was performed in collaboration with Lisa Lister. 
 
 
3.4.2 Sgo2 becomes enriched on chromosomes during the transition from 
prophase to metaphase of MI 
In view of the results presented above, it was of particular interest to investigate 
the relationship between cohesin and Sgo2 depletion. Therefore, we asked 
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whether Sgo2 is recruited on the chromosomes during prophase arrest of 
oocytes. To address this question, chromosome spreads from fully-grown 
prophase-arrested oocytes were prepared and stained for Sgo2 and CREST, 
using the same techniques as for prometaphase oocytes. The findings indicate 
that at this stage most of Sgo2 is localised into the nucleolus and only a small 
fraction appears to colocalise with DNA (Fig 3.4). For the time being, although 
it is still unclear at which stage during the oocyte’s development Sgo2 is 
recruited on the chromosomes, it could positively be argue that Sgo2 
localisation on the chromosomes is gradually increased during transition from 
late prophase to metaphase of MI. Thus, Sgo2 might not be playing its putative 
protective role during the prolonged prophase-arrest. 
 
 
Figure 3.4 Localisation of Sgo2 in GV-stage mouse oocytes 
Image of the nucleus of a fully-grown prophase I-arrested oocyte stained (IF) for Sgo2 and 
CREST, using the same techniques as for prometaphase oocytes. It appears that at this stage 
most of Sgo2 is localized into the nucleolus with only a small fraction colocalised with DNA. 
 
3.4.3 Sgo2 levels are reduced in Smc1β-/- mouse oocytes 
The next step was to investigate the possibility that the observed recruitment of 
Sgo2 in oocytes from aged females might as well be a consequence and not 
exclusively a putative causative factor of cohesin depletion. To assess that, we 
have used the Smc1β knockout mouse (Revenkova et al., 2004). In mouse 
meiocytes, Smc1β is involved in maintenance of sister chromatid cohesion, and 
in Smc1β-/- oocytes defective sister chromatid cohesion has been shown to lead 
to a massive increase in aneuploidy (Revenkova et al., 2004), which is further 
amplified by age (Hodges et al., 2005). If Sgo2 levels in Smc1β depleted oocytes 
are equal with that of Smc1β wild type oocytes, it would imply that levels of 
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chromosome-associated Sgo2 are independent of the levels of the established 
chromosome-associated cohesin.  
 
Chromosome spreads from Smc1β+/+ and Smc1β-/- late prometaphase (GVBD+5h) 
oocytes were prepared and immunolabeled (IF) for Sgo2 and CREST 
(Chromosome spreads were prepared by Lisa Lister). Analysis of the IF signal 
has shown that Smc1β-/- oocytes exhibit lower levels of chromosome associated 
Sgo2 (Fig 3.5.A/B). This indicates that in mouse oocytes, cohesin is either 
directly or indirectly required for recruitment of Sgo2. This is consistent with 
results from studies on maze meiosis (Hamant et al., 2005). 
 
Figure 3.5 Reduced levels of chromosome-associated Sgo2 in Smc1β-/- mouse 
oocytes 
(A) Representative images of chromosome spreads of oocytes at late prometaphase (GVBD+5h) 
from Smc1β+/+ mice (n = 32 from three mice) and Smc1β-/- mice (n = 20 from three mice), stained 
(IF) for Sgo2 and CREST. Sgo2 levels on chromosomes of Smc1β-/- mice appear reduced. Note 
loss of bivalent association Smc1β-/ oocytes due to depleted cohesin levels. Chromosomes 
surrounded by white boxes are shown in the enlarged images. Scale bar represents 10 μm. (B) 
3D surface plots of images in (C) showing reduced Sgo2 fluorescence intensity on chromosomes 
of Smc1β-/- oocytes compared with wild-type oocytes. This experiment was performed in 
collaboration with Lisa Lister. 
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3.5 Discussion 
This chapter represents an investigation of the hypothesis that cohesin loss 
during the protracted arrest of oocytes at prophase I is a leading causative 
factor of age-related aneuploidy. Overall, I have presented evidence that 
chromosome-associated Rec8 is reduced in growing and fully grown prophase 
arrested oocytes of aged mice (Fig 3.1) and this decrease correlates with an 
increase in the distance between sister chromatid centromere during late 
prometaphase (Fig 3.2). Moreover, we found that Sgo2 becomes enriched on 
chromosomes during the transition from prophase to metaphase of MI (Fig 3.4) 
and that this is markedly reduced in oocytes of aged mice (Fig 3.3). Finally, we 
have shown that Sgo2 is reduced in oocytes of Smc1β-/- mice (Fig 3.5). 
3.5.1 Cohesin depletion in oocytes of aged mice 
Previous studies investigating the effect of cohesin depletion in vertebrate 
meiocytes has depended on the introduction of genetic perturbations. Mouse 
strains deficient for SMC1 and REC8 have been generated, giving rise to sterile 
female and male mice (Bannister et al., 2004; Revenkova et al., 2004). Rec8-/- 
spermatocytes exhibited abnormal synapsis and deficiency in sister chromatid 
cohesion, and in Rec8-/- females the oocyte pool disappeared during embryonic 
development, thus precluding the use of this strain for research into oocyte 
ageing (Bannister et al., 2004; Xu et al., 2005). Smc1 KO mice, although they are 
also sterile, provided evidence that cohesin is a prime candidate for the 
molecular link between female age and oocyte aneuploidy. This strain exhibits 
an accelerated age-related loss of oocytes, which almost disappeared after 8 
months of age and even young mice exhibit premature loss of sister chromatid 
cohesion along chromosome arms and at centromeres (Revenkova et al., 2004; 
Hodges et al., 2005). Importantly, SMC1 deficient oocytes show a striking age-
depended destabilisation of chiasmata, resulting in an accumulation of distally 
associated and separated homologues during metaphase I (Hodges et al., 2005). 
In a study investigating cohesin behaviour outside the context of genetically 
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engineered mice, it has been reported that premature sister chromatid 
separation strongly correlated with reduced levels of chromosome associated 
REC8, SMC1 and STAG3 in oocytes from older females (Liu and Keefe, 2008). 
However, the latter study utilized a senescence-accelerated wild-type mouse 
strain, and since the molecular basis for ageing-acceleration is yet unknown, the 
conclusion might not describe accurately the mechanisms involved in age-
associated loss of cohesion. 
 
Unlike the experimental systems described above, here we have used oocytes of 
a long-lived, non-mutant mouse model, which we have shown to exhibit age-
related loss of cohesin amongst other meiotic defects in oocytes (Lister et al., 
2010).  The conclusion that oocyte chromosomal cohesin was depleted during 
female ageing was based on analysis of prometaphase of MI chromosomes 
(Lister et al., 2010), however, as ageing is characterised by prolonged prophase 
arrest, a key question was whether cohesin is already depleted during prophase 
arrest. To test this I have measured colocalisation of Rec8 and DNA in fully 
grown and growing prophase-arrested oocytes. Compared with prometaphase 
of MI chromosomes, the chromatin of prophase-arrested oocytes is diffuse and 
is enclosed in the nucleus (GV). Moreover, the chromatin configuration 
appeared to vary widely and is probably influenced by transcriptional activity 
in the growing oocyte. Furthermore, the centromeric CREST signal used to 
normalize cohesin levels on prometaphase of MI chromosomes, were not 
distinct in many oocytes. This made it difficult to perform a quantitative 
assessment of chromosome –associated cohesin levels.  To address this 
problem, I have employed the use of fluorescence intensity 3D surface plots.  
 
My findings (Fig 3.1) indicate that loss of cohesion takes place during the 
growing phase of prophase-arrested oocytes. What mechanisms could be 
responsible for this loss? Is cohesin being actively replenished in growing 
prophase-arrested oocytes or does the oocyte rely just on the cohesin that is 
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loaded on meiotic chromosomes during fetal development? If the former is true 
then the observed cohesin loss in aged oocytes would imply a decline in this 
putative cohesin-reloading process and/or a decrease of cohesin reserves, likely 
due to impaired expression. Two recent mouse studies have elegantly 
addressed these questions and have surprisingly shown that cohesin loaded 
onto chromosomes during fetal development is sufficient to maintain cohesion 
even in aged oocytes (Revenkova et al., 2010) and that there is little or no 
cohesin replenishment on meiotic chromosomes during postnatal prophase I 
arrest (Tachibana-Konwalski et al., 2010). So, considering that low levels of 
Smc1 transcripts have been detected in growing oocytes (Hodges et al., 2005; 
Revenkova et al., 2010), and that Rec8 protein levels appear to be similar 
between young and aged mice (Chiang et al., 2010) the data I present here 
suggest that de novo cohesin synthesis is insufficient and probably not used for 
counteracting the depletion of chromosomal cohesion during ageing. 
 
Various assumptions could be made regarding the mechanism(s) responsible 
for cohesin loss during prophase arrest. It is likely that the observed age-related 
depletion of cohesin could be due to degeneration of cohesin subunits, for 
example by oxidative stress. Alternatively, a mechanism that protects cohesin 
might be in place during prophase arrest and its gradual deterioration during 
ageing could lead to premature removal of cohesin from chromosomes. It is 
also conceivable that cohesin removal might be caused by a low background 
activity of either separase or a meiotic equivalent of the mitotic “prophase 
pathway”. Prolonged exposure to such a “cohesin-hostile” environment could 
provide a simple explanation for the cohesion depletion phenomenon in aged 
oocytes.   
 
The next crucial step in this work is to establish whether cohesin loss is 
confined to the oocyte growth phase, or whether it is also a feature of 
primordial oocytes, which represents a relatively quiescent state, in which 
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oocytes remain for the vast majority of their lifespan.    This question is the 
subject of ongoing research in the lab.  
3.5.2 Female ageing is associated with loss of the closely apposed structure of 
sister kinetochores required for their monopolar attachment  
Apart from maintaining the integrity of bivalent and dyad chromosomes until 
anaphase I and anaphase II, respectively, (Watanabe, 2005) cohesin plays 
another important role during MI. Studies in fission yeast indicate that cohesin 
at the core centromere promotes the establishment of monopolar attachment of 
sister kinetochores on the MI spindle, by keeping sister centromeres closely 
apposed (Watanabe and Nurse, 1999; Sakuno and Watanabe, 2009). Studies in 
plants have also provided similar evidence supporting the role of centromeric 
cohesin in the establishment of correct Kt-Mt attachments during MI 
(Chelysheva et al., 2005; Li and Dawe, 2009).  
 
The depletion of cohesin in aged mouse oocytes (Lister et al., 2010) prompted us 
to investigate whether sister centromeres have lost their tight association. 
Indeed, based on centromere staining, I have shown here that the majority of 
sister centromeres in aged oocytes appear as two distinct foci, whereas in young 
oocytes they are predominantly merged into a single focus (Fig 3.2.A/B). By 
measuring the distance between the extremities of the CREST signals at sister 
centromeres, I found that the inter-centromeric distance is increased in aged 
oocytes compared to young ones (Fig 3.2.C). These results are consistent with 
findings in another naturally aged mouse strain (Chiang et al., 2010) and 
indicate that reduced centromeric cohesin levels at MI are associated with a 
failure of sister centromeres to maintain their tightly apposed structure. Given 
the importance of centromeric cohesion for correct Kt-Mt attachments in other 
organisms, it is likely that separation of sister Kts during prometaphase of MI 
creates a bias against monopolar attachment of sisters. In support of this, live-
cell imaging of oocyte chromosomes during progression through MI, revealed 
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that the majority of oocytes from aged mice showed anaphase defects ranging 
in severity, from a single lagging chromosome, to large clumps of chromatin 
trapped in the spindle mid zone (Lister et al., 2010).  These defects are 
considered to be the hallmark of erroneous Kt-Mt attachments (Sakuno et al., 
2011).  Thus, splitting of sister centromeres may be a major contributor to age-
related missegregation during MI, by creating unpropitious prospects for stable 
biorientation and segregation of homologous chromosomes. 
 
3.5.3 The role of Sgo2 in cohesin depletion 
Mouse Sgo2 has been shown to be essential for protecting centromeric cohesin 
during anaphase I (Lee et al., 2008; Llano et al., 2008).  Several lines of evidence 
indicate that cohesin is lost from centromeres in oocytes from aged mice. First, 
immunofluorescence labeling revealed reduced levels of centromeric Rec8 in 
oocytes of aged mice (Lister et al., 2010). Second, complete loss of centromeric 
cohesion leading to premature separation of sisters was prevalent in MII 
oocytes from aged mice (Lister et al., 2010). Moreover, the increased distance 
between sister centromeres discussed above is likely linked to cohesin depletion 
at centromeres. Together these findings raise the possibility that the 
mechanisms responsible for protecting cohesin at centromeres are 
compromised during female ageing.  To address this we have measured and 
compared the levels of chromosome associated Sgo2, between young and aged 
oocytes. Our findings indicate that Sgo2 is actually massively reduced in aged 
oocytes (Fig 3.3). 
 
Interestingly, we found that Sgo2 localises to chromosome arms in young 
oocytes during prometaphase of MI (Fig 3.3A). Unpublished live-cell imaging 
data (Ahmed Rattani; Nasmyth Lab) also suggest that Sgo2 localises along the 
entire chromosome during prometaphase I and is gradually restricted to the 
centromere prior to anaphase I. It is conceivable that Sgo2 and its partner PP2A 
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might be protecting arm cohesin to ensure timely removal by separase during 
exit from MI.  Possible mechanisms by which cohesin might be removed before 
the onset of anaphase I, could involve phosphorylation of cohesin subunits 
promoting its dissociation in a prophase pathway-like manner. 
 
The above data raised the possibility that Sgo2 might be protecting cohesin 
prior to anaphase I. However, my findings indicate that Sgo2 becomes enriched 
on chromosomes during the transition from prophase to metaphase of MI (Fig 
3.4), indicating that it is recruited at this stage. Therefore, although we cannot 
exclude the possibility that Sgo2 might move on and off the chromosomes 
during prophase arrest, the data suggest Sgo2 is unlikely to be guarding 
cohesin’s integrity during prophase arrest. 
 
Finally, in this chapter we have shown that the level of chromosome-associated 
Sgo2 was reduced in oocytes of Smc1-/- mice (Fig 3.5). This observation, 
consistent with findings in maize meiosis (Hamant et al., 2005), suggests that 
Sgo2 depletion could be a consequence of cohesin loss. Therefore, we propose a 
model where cohesin loss during prophase arrest impairs recruitment/retention 
of Sgo2 during prometaphase I, thereby amplifying further cohesin depletion 
during prometaphase I. This could subsequently lead to cohesin depletion 
below the 10% threshold (Chiang et al., 2010), thus promoting chromosome 
missegregation. Given that recruitment of Sgo2 to centromeres appears to be 
regulated by various factors, including Bub1 (Kitajima et al., 2004; Huang et al., 
2007) and Aurora B (Huang et al., 2007) kinase activities, and that recently 
MAD2 was identified to interact with SGO2 in human and X. laevis (Orth et al., 
2011), our observation that Sgo2 is depleted in aged oocytes actually raises 
many questions regarding its etiology and possible repercussions.  
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 . Characterisation of Plk1 mediating Chapter 4
chromosome segregation during Meiosis I of the mouse 
oocyte 
4.1 Introduction 
Mammalian oocytes arrest at prophase of meiosis I (MI) during embryonic 
development and only resume meiosis when they receive the appropriate 
ovulatory cues. Meiotic resumption leads to a reductional chromosome 
segregation followed by an immediate entry into meiosis II (MII), without an 
intervening round of DNA replication, and a subsequent arrest at metaphase. 
Upon fertilisation MII resumes leading to an equatorial chromosome 
segregation, after which the zygote enters interphase. Meiotic resumption and 
passage through the two rounds of chromosome segregation of meiosis 
demands a high level of coordination of cellular processes to ensure accurate 
chromosome segregation and to prevent aneuploidy. Synchronization of 
meiotic events is achieved through an intrinsically complex interplay of 
interconnected regulatory pathways, where kinases and phosphatases play 
central roles. Cyclin-dependent kinases (Cdks), Aurora kinases and Polo-like 
kinases (Plks) are key to regulating various meiotic processes including meiotic 
arrest/progression, chromosome dynamics and spindle assembly/disassembly. 
This chapter focuses on the role of Plk1 during MI. 
 
A significant step in uncovering the roles of Plk1 during mitosis has been the 
recent development and application of specific small-molecule inhibitors 
allowing acute inactivation of Plk1. The dihydropteridinone BI 2536, an ATP-
competitive drug, is currently the best-established small-molecule inhibitor of 
Plk1 (Lenart et al., 2007; Steegmaier et al., 2007). It exhibits a potent and highly 
selective function as it can inhibit Plk1 in vitro with an IC50 of 0.83nM, while 
showing negligible activity against a panel of 63 other kinases (Steegmaier et al., 
2007). There are several advantages in the use of BI 2536 to study Plk1 function 
during meiosis. Firstly, it is highly penetrant and acts fast, thus allowing precise 
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temporal control of Plk1 inhibition at any desired stage. Moreover, it can be 
combined with other treatments, its effect is reversible and by varying the 
applied dose, various phenotypes could be revealed. Importantly, although it 
inhibits the enzymatic function of Plk1, it still allows the kinase to function as a 
scaffold for protein-protein interactions, which would not be feasible if other 
methods of inactivation, such as RNA interference or genetic modification, 
were applied (Taylor and Peters, 2008). 
 
Previous studies have shown that the activity of Plk1 increases during meiotic 
maturation, but little is known about its function in oocytes. This chapter aims 
to perform a functional analysis of Plk1 in mammalian oocytes. To achieve that 
the chemical inhibitor of Plk1, BI 2536 has been used in combination with 
indirect immuno-fluorescence (IF) staining and live-cell imaging of oocytes 
injected with mRNAs encoding fluorescent proteins. 
 
4.2 Plk1 is recruited to the kinetochore after release from prophase I arrest 
Enzymes do not just wander aimlessly inside the cell. Their localisation is 
directly associated and indicative of their function and vice versa. Therefore, a 
first step in investigating the role of Plk1 during meiotic maturation was to 
identify its localisation. To achieve that, fully-grown oocytes from CD1 mice 
were harvested at the GV stage and were allowed to undergo MI. Chromosome 
spreads were produced using oocytes at the GV-stage, early prometaphase I, 
late prometaphase I and Met-II arrest (Fig 4.1).  
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Figure 4.1 Experimental design. 
Diagrammatic representation of the experimental methodology.  Mature prophase arrested 
oocytes were harvested from CD1 mice and were allowed to undergo MI in media with or 
without BI 2536. 
 
IF staining against Plk1 and CREST revealed that Plk1 is localised near the 
CREST foci at the GV-stage (Fig 4.2A), to the centromere of prometaphase I 
chromosomes (Fig 4.2B,C) and to the centromere of Met-II arrested 
chromosomes (Fig 4.2D), albeit at much lower levels compared to centromeric 
prometaphase I levels. A first look of the chromosome spreads at prometaphase 
I gives the impression that Plk1 shows both inner- and outer-centromere 
localisation. However, upon closer inspection Plk1 foci actually appear to have 
a common orientation on each individual chromosome spread (e.g. in Fig 4.2B 
they all “look” south, whereas in Fig 4.2C they all “look” west). This orientation 
suggests that Plk1 is localised to the kinetochore, which during the process of 
chromosome spreading may collapse on either side of the centromeric CREST 
foci, thus giving the wrong impression of being at the inner-centromere region 
of chromosomes. Similar observations were made for Met-II stage chromosome 
spreads, suggesting that during that stage of meiosis Plk1 is also localised to the 
kinetochore region of chromosomes.  
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Figure 4.2 Plk1 is enriched at the centromere upon meiotic resumption. 
(A) Images show the nucleus of a prophase-arrested (GV-stage) oocyte. Representative images 
show DNA, Plk1, and CREST staining in the nucleus of a fully-grown GV-stage oocyte (n = 7 
oocytes from three mice). (B) Representative images showing DNA, Plk1, and CREST staining 
of chromosome spreads prepared during early prometaphase of MI (GVBD + 2 hr). (C) 
Representative images showing DNA, Plk1, and CREST staining of chromosome spreads 
prepared during late prometaphase of MI (GVBD + 5 hr). (D) Representative images showing 
DNA, Plk1, and CREST staining of chromosome spreads prepared at the MetII-arrest stage. 
Notably, samples had to be exposed to the appropriate excitation wavelength for longer 
compared to (B) and (C) in order to “visualise” the Plk1 signal at the centromere of Met-II 
oocytes. Plk1 and CREST foci (A) and chromosomes (B, C, D) surrounded by white boxes are 
shown in the enlarged images. Scale bars represent 10 μm. 
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4.3 BI 2536 does not prevent recruitment of Plk1 to the kinetochore during MI 
Next step was to assess the effect of BI 2536 on chromosome localisation of Plk1. 
Fully-grown oocytes from CD1 mice were harvested at the GV stage and were 
allowed to undergo MI in media supplemented with 6.25nM BI 2536 (Fig 4.1). 
Chromosome spreads were prepared using oocytes at early and late 
prometaphase of MI. Staining against Plk1 and CREST revealed that Plk1 
localised to the kinetochore of prometaphase I chromosomes (Fig 4.3). These 
results suggest that the concentration of BI 2536 used here does not prevent 
recruitment of Plk1 to the kinetochore during meiotic resumption. 
Interestingly, the chromosomes of BI 2536-treated oocytes were characterised 
by extremely short chromosome arms (e.g. Fig 4.3.B/enlarged image). As it will 
be shown in later images (Fig 4.6), this hyper-condensation effect became more 
severe as the concentration of BI 2536 increased. This observation is consistent 
with previous studies describing chromosome condensation defects when Plk1 
function was perturbed (Losada et al., 2002; Gimenez-Abian et al., 2004; Jeong et 
al., 2010). These results suggest that Plk1 kinase activity is required to curtail 
chromosome condensation.  
 
Figure 4.3 BI 2536 does not prevent recruitment of Plk1 to the kinetochore during 
MI. 
Representative images showing DNA, Plk1, and CREST staining of chromosome spreads 
prepared using oocytes cultured in media supplemented with 6.25nM BI 2536 (A) during early 
prometaphase (GVBD + 2 hr) and (B) late prometaphase (GVBD + 5 hr) of MI. Chromosomes 
surrounded by white boxes are shown in the enlarged images. Scale bars represent 10 μm. 
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4.4 BI 2536 does not affect the timing of entry into prometaphase of MI in 
mouse oocytes 
Previous studies on somatic cells have reported that BI 2536 causes a significant 
delay in Nuclear Envelope Breakdown (NEB) during mitosis. In order to assess 
if BI 2536 has a similar effect on GVBD (entry into prometaphase) during oocyte 
MI, I performed a series of in vitro dose-response experiments. 
 
4.4.1 Effect on the timing of GVBD with short exposure to BI 2536 
Fully-grown oocytes from CD1 mice were harvested at the GV stage and were 
allowed to undergo MI in control medium and medium supplemented with 
3/4/6.25/12.5 and 25nM BI 2536. Under control conditions, GVBD normally 
occurs within 1h of removal from IBMX, which maintains arrest at the GV stage 
by inhibiting cAMP phosphodiesterases and maintaining high cAMP levels 
inside the oocyte (Schultz et al., 1983). Moreover, based on empirical 
observations, oocytes that undergo GVBD within 1 to 2 hours of removal from 
IBMX are competent to successfully reach the MetII arrest stage. 
 
 In this set of experiments the percentage of oocytes in each group that 
underwent GVBD within 1.5-2h varied in the range of 75-100% (Fig 4.4A) and 
statistical analysis showed that the concentrations of BI 2536 used had no 
significant effect on the timing of GVBD (P>0.05).  
 
Thus, consistent with what has been observed previously (Vanderheyden et al., 
2009), the tested BI 2536 concentrations do not cause a delay in GVBD in oocyte 
meiosis.  
 
4.4.2 Effect on the timing of GVBD with prolonged exposure to BI 2536 
Small molecule chemical inhibitors such as BI 2536 are generally highly 
penetrant and exhibit a rapid biochemical effect even at low concentrations 
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(Steegmaier et al., 2007). In order to eliminate the possibility that absence of an 
effect on GVBD timing might be due to delayed action of BI 2536, I decided to 
prolong the exposure to BI 2536 to 48h, prior to releasing the oocytes from 
prophase arrest.   
 
 Fully-grown prophase arrested oocytes were harvested from CD1 mice and 
were cultured in control medium and medium supplemented with 6.25nM BI 
2536. Both media were also supplemented with IBMX in order to keep oocytes 
arrested at prophase of MI. After 48h of incubation oocytes were transferred to 
control medium and medium supplemented with 6.25nM BI 2536, and were 
allowed to resume MI. The average percentage of oocytes in each group that 
underwent GVBD within 1.5-2h varied between 80% and 100% (Fig 4.4B). 
Statistical analysis of these results showed that prolonged incubation at 6.25nM 
BI 2536 did not impede the transition from prophase-arrest (GV) to 
prometaphase of MI compared to control (P=0.5).  
 
Moreover, comparing these results with the previous relevant results (i.e. 
Control, 6.25nM BI 2536) from short exposure to BI 2536, leads to the conclusion 
that GVBD timing remains unaffected with either short or prolonged exposure 
to 6.25nM BI 2536 (P>0.05).  
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Figure 4.4 BI 2536 does not affect the timing of entry into prometaphase of MI 
(A) Average percentage of oocytes undergoing GVBD in 1.5-2h at various BI 2536 
concentrations: Control, 92.87% (±7.47% SD); 3nM BI2536, 100% (±0% SD), 4nM BI 2536, 94.88% 
(±2.19% SD); 6.25nM BI 2536, 88.33% (±10.57% SD); 12.5nM BI 2536, 90.26% (±9.22% SD); 25nM 
BI 2536, 87.79% (±15.75% SD). No significant difference was observed between the different 
groups (P>0.05). (B) Average percentage of oocytes undergoing GVBD in 1.5-2h after exposure 
to 6.25nM BI 2536 for 48h: Control, 88.33% (±6.41% SD); 6.25nM BI 2536, 93.75% (±10.82 SD). No 
significant difference was observed between the two groups (P=0.5). Errors bars indicate ±SD. 
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4.5 BI 2536 inhibits exit from MI in a dose-dependent manner 
Once I established that prolonged exposure to BI 2536 was not necessary to 
exert its effect, the next step was to investigate for possible effects on the ability 
of oocytes to exit MI and extrude their first PB. As previously, fully grown, 
prophase arrested oocytes from CD1 mice were harvested and were allowed to 
progress through MI in control medium and medium supplemented with 
3/4/6.25/12.5 and 25nM BI 2536. After 20h of culture, oocytes that had 
completed MI, as assessed by the presence of the first PB, were scored in each 
group. I also prepared chromosome spreads to verify the scored numbers and 
avoid mistakes due to oocytes retracting their PBs. Under normal conditions, 
the first PB extrusion occurs 10-12h after release from prophase arrest. 
 
In this set of experiments, concentration as low as 3nM and 4nM BI2536 did not 
have an effect on the ability of oocytes to exit MI, compared with control 
oocytes (P>0.05) (Fig 4.5). However, at higher concentrations the proportion of 
oocytes in each group that did not exit MI increased in a dose-dependent 
manner, ranging from 54.76% (±16.84% SD) in 6.25nM to 100% in 25nM BI 2536 
(P<0.05) (Fig 4.5).   
 
Overall, these results indicate that BI 2536 inhibits exit from MI in a dose-
dependent manner, with 25nM producing a fully penetrant phenotype.  
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Figure 4.5 BI 2536 inhibits exit from MI in a dose-dependent manner 
The graph shows the average percentages of oocytes that exit MI and arrest at MI with 
increasing concentrations of BI 2536: Control, 14.09% (±18.64% SD); 3nM BI2536, 24.29% (±6.06% 
SD), 4nM BI 2536, 16.53% (±13.28% SD); 6.25nM BI 2536, 54.76% (±16.84% SD); 12.5nM BI 2536, 
81.62% (±21.24% SD); 25nM BI 2536, 100% (±0% SD). Statistical analysis of these results showed 
a significant difference between the following groups: Control vs. 6.25/12.5/25nM; 3/4nM vs. 
12.5/25nM; 6.25nM vs.25nM (P<0.05). Notably, 25nM of BI 2536 are adequate to produce a fully 
penetrant phenotype. Error bars indicate +SD.   
4.5 Oocytes arrested in MI in the presence of BI 2536 do not undergo 
anaphase. 
Previous studies have shown that BI 2536 can inhibit mitotic M-phase at 
different stages depending on the timing of application; early application could 
inhibit anaphase, whereas late application may allow anaphase and inhibit 
cytokinesis (Taylor and Peters, 2008). Could a mixture of these phenotypes arise 
in the subset of oocytes that arrest in MI? In other words, a visual microscopic 
assessment was not sufficient to classify an MI arrested oocyte, as anaphase 
might have occurred, but without being followed by cytokinesis and 
subsequent polar body extrusion. In order to assess at which stage of MI the BI 
2536-treated oocytes were arrested, I produced chromosome spreads and IF 
stained them against CREST. The results revealed the presence of intact 
bivalents (Fig 4.6) in MI arrested oocytes in all tested BI 2536 concentrations. 
This clearly suggests that in this particular subset of oocytes, which arrest in MI 
in the presence of BI 2536, the mechanism of anaphase is inhibited.   
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Figure 4.6 BI 2536 inhibits anaphase I 
(See legend on next page) 
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Figure 4.6 BI 2536 inhibits anaphase I 
Representative images showing DNA and CREST staining of chromosome spreads prepared 
from oocytes arrested in MI after overnight incubation in increasing BI 2536 concentrations; A, 
control; B, 3nM; C, 4nM; D, 6.25nM; E, 12.5nM; F, 25nM. Chromosomes surrounded by white 
boxes are shown in the enlarged images. Scale bars represent 10 μm. 
 
4.5.1 BI 2536 increases inter-centromere distance during prometaphase of MI 
In previous immunofluorescence staining experiments I noticed from the 
CREST staining that sister centromeres appear to be further apart during late 
prometaphase of MI (GVBD+5hr) in oocytes treated with BI 2536 compared to 
control oocytes (Fig 4.3). This observation suggested that centromeric cohesion, 
which is required to closely appose sister kinetochores for accurate monopolar 
sister kinetochore-spindle attachment to be established (Sakuno and Watanabe, 
2009) might be weakened in BI 2536-treated oocytes. However, as it will be 
shown in the next chapter this does not appear to be the case. Nevertheless, 
such disrupted sister centromere configurations could lead to erroneous Kt-Mt 
attachments, which might be the underlying cause of the observed 
prometaphase I arrest. 
 
In order to examine for a possible disruption in sister centromere integrity, the 
inter-centromeric distances were measured and compared between late 
prometaphase I (GVBD+5h) control oocytes and oocytes matured in media 
supplemented with 6.25nM BI 2536 (Fig 4.7.A). Distances between sister 
centromeres were measured by identifying the peaks of CREST fluorescence 
(Fig 4.7.B; each peak represents the center of a sister  centromere) and 
calculating the distance between them. Consistent with our previous 
observation, it was found that inter-centromere distances significantly (P<0.05) 
increased in BI 2536 treated oocytes compared to control oocytes (Fig 4.7.C). 
These results indicate that the close apposition of sister centromeres, which is 
required for the establishment of monopolar sister kinetochore-microtubule 
attachment (Hauf and Watanabe, 2004; Brar and Amon, 2008), is affected in 
oocytes in the presence of BI 2536.  
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Figure 4.7 BI 2536 increases inter-centromere distance in prometaphase of MI 
(A) Representative images showing DNA and CREST staining of chromosome spreads 
prepared from control and 6.25nM BI2536-treated oocytes, at late prometaphase I (GVBD+5h). 
Scale bars represent 10μm. (B) The outlined regions in A enlarged with DNA omitted. Plotted is 
the intensity profile of the CREST (red) signal measured along a line (white) drawn across the 
centromere. x represents inter-centromere distance. (C) Frequency distribution of the distance 
between sister centromeres (x), measured from the CREST signals in control (n = 113 
centromeres; 4 oocytes from three mice) and BI 2536-treated (n = 134 centromeres; four oocytes 
from three mice) oocytes, showing a significantly greater mean distance in the 6.25nM BI 2536-
treared compared with control oocytes (P < 0.05). 
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4.5.2 BI 2536 increases the number of erroneous Kt-Mt attachments at 
prometaphase of MI 
In view of the increased distance between sister centromeres, I next asked 
whether the establishment of Kt-MT attachments is disrupted in BI 2536-treated 
oocytes. To address this question, control oocytes and oocytes cultured in 
medium supplemented with 6.25nM or 25nM BI 2536 were briefly treated with 
Ca2+-buffer and fixed shortly prior to anaphase (GVBD+6h). As kinetochore 
microtubules (K-fibers) are differentially stable to Ca2+-buffer treatment in 
comparison to non-kinetochore microtubules, a short treatment allows an easier 
assessment of Kt-Mt attachments. Following IF staining against CREST and -
Tubulin, images of the whole spindle were acquired by means of scanning 
confocal microscopy.  
 
One of the first observations was that in contrast to findings in mitosis, where 
BI 2536 induces the formation of monopolar spindles (Lenart et al., 2007), the 
meiotic spindle geometry appears to remain overall unaffected at the BI 2536 
concentrations used in this study (Fig 4.8.A/B). 
 
Next step was to determine the effect of BI 2536 on chromosome 
congression/alignment. To achieve this, bivalents were individually assessed 
for congression, by measuring the distance of their kinetochores from the 
spindle equator. Bivalents with both pairs of sister kinetochores situated further 
than 4m of the spindle equator were classified as non-aligned, and those with 
both pairs of kinetochores inside this radius were classified as aligned (Fig. 4A). 
Results indicate that maturation in 25nM BI 2536-supplemented medium leads 
to significant congression defects at late prometaphase of MI (P<0.05; Fig 4.8.C).  
 
Further analysis of the oocytes cultured in 25nM BI 2536 revealed that almost 
57% of them exhibited severe bivalent misalignment (Fig 4.8.D), having at least 
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one bivalent with all four centromeres attached to a single pole (Fig 
4.8.E/”Failed”). In addition, the increased distance between sister centromeres 
in the presence of BI 2536 (Fig 4.8.F/25nMBI2536/”Monopolar”2, 3) was also 
evident from these whole mount preparations, consistent with the data 
obtained previously from chromosome spreads (Fig 4.7). 
 
Overall, these data indicate a dose-dependent effect of BI 2536 on the 
establishment of correct Kt-Mt attachments indicating the Plk1 kinase activity is 
required to promote bipolar attachment of bivalents.  This raises the possibility 
that inhibition of anaphase by BI 2536 might be due to activation of the SAC.  
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Figure 4.8 BI 2536 increases the frequency of erroneous Kt-Mt attachments at 
late prometaphase of MI. 
(See legend on next page) 
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Figure 4.7 BI 2536 increases the frequency of erroneous Kt-Mt attachments at 
late prometaphase of MI 
(A) Schematic representation of a meiotic spindle in late prometaphase of MI. Bivalents with all 
kinetochores being further than 4μm from the spindle equator were classified as non-aligned; λ 
indicates the measured spindle length. (B) Graph showing spindle length at late prometaphase 
of MI (GVBD+6h) in control oocytes and oocytes cultured in media supplemented with 
6.25/25nM BI 2536: Control, 25.95μm (±3.5μm SD); 6.25nM, 24.38μm (±3.3μm SD); 25nM, 
24.83μm (±2.3μm SD). No significant differences were observed between analysed groups 
(P≥0.05); red lines indicate individual mean values. (C) Graph showing number of non-aligned 
bivalents at late prometaphase of MI (GVBD+6h) in control oocytes and oocytes cultured in 
media supplemented with 6.25 or 25nM BI 2536: Control, 0.12(±0.6 SD); 6.25nM, 0.78 (±1.6 
SD);25nM, 1.9 (±1.9 SD). Asterisk indicates groups exhibiting significant difference from one 
another (P<0.05); red lines indicate individual mean values. (D) Graph showing the percentages 
of oocytes with aligned and non-aligned bivalents in the 25nM BI 2536 group from (C). Oocytes 
with non-aligned bivalents are further categorized into “Mild” and “Severe” misalignment 
groups. Oocytes with a bivalent attached to a single pole (e.g. Failed in (F)) were classified as 
exhibiting “Severe” misalignment. (E) Representative images showing DNA, CREST and α-
Tubulin staining of oocytes at late prometaphase (GVBD+6h) after maturation in control media 
or media supplemented with 25nM BI 2536. Prior to fixation, oocytes were briefly treated with 
Ca2+-buffer. The top row shows maximum intensity Z projection images across the whole 
spindle, whereas the bottom row shows Z projection images of four selected sections from the 
same oocytes. Numbered circled regions indicate the kinetochores magnified in (E). Scale bars 
represent 1μm. (F) Enlarged images showing examples of kinetochore-microtubule attachments 
in the oocytes shown in (D). Kinetochore-microtubule attachments are classified into three 
categories: Monopolar (green), Undefined (yellow) and Failed (red). The images are colour-
coded according to these categories. Note the increased inter-centromeric distance in BI 2536-
treated oocytes (Monopolar-2, 3), where the 2 K-fibers can be distinguished from one another, 
compared to control oocytes, where the 2 K-fibers appear as one. 
 
4.6 Plk1 is required for efficient activation of APC/CCdc20 during exit from MI. 
4.6.1 BI 2536 inhibits securin degradation in MI. 
In mitotic cells the SAC acts as a surveillance mechanism to ensure that the 
onset of anaphase is delayed until all chromosomes establish stable bipolar 
kinetochore microtubule attachments (Peters, 2006).  The wait-anaphase signal 
generated from unattached Kts inhibits APC/C-mediated degradation of cyclin 
B and securin, thereby inhibiting activation of separase-mediated cleavage of 
cohesin (Musacchio and Salmon, 2007).  Studies in oocytes indicate that the 
timing of cyclin B and securin degradation required for the onset of anaphase of 
MI (Herbert et al., 2003), is regulated by the SAC (Homer et al., 2005b; 
McGuinness et al., 2009). 
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Having established that BI 2536 severely compromises chromosome attachment 
and alignment, the next step was to investigate whether inhibition of anaphase 
in the presence of 25nM BI 2536 was a consequence of sustained activation of 
the SAC in the presence of erroneous Kt-Mt attachments. To address this 
question, fully-grown prophase-arrested CD1 oocytes were co-injected with 
mRNA encoding securin-YFP and H2B-RFP and were imaged by time-lapse 
microscopy during maturation in control or 25nM BI 2536-supplemented 
media, for approximately 16h (Fig 4.9.A). For these experiments, I used 25nM of 
BI 2536, because this concentration produced a single phenotype, where all 
oocytes arrest at prometaphase of MI (Fig 4.5). Analysis of the time-lapse 
movies showed that in control oocytes securin-YFP fluorescence declines about 
6h post-GVBD (Fig 4.9.B/C), prior to anaphase and subsequent polar body 
extrusion (PBE) at 8.3h (±1.15h SD) post-GVBD (Fig 4.9.C). In contrast, in BI 
2536-treated oocytes, securin-YFP FI does not decline (Fig 4.9.B/D) indicating 
that BI 2536 inhibits degradation of securin and subsequently the onset of 
anaphase and PBE (Fig 4.9.D). However, in contrast to control oocytes, securin-
YFP did not accumulate during progression through prometaphase I. This 
could be due either to a low level of degradation or to suppression of 
translation of securin-YFP mRNA. 
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Figure 4.9 BI 2536 inhibits the degradation of securin in late metaphase of MI 
(A) Schematic representation of experimental design: CD1 oocytes were co-injected with mRNA 
encoding securin-YFP and H2B-RFP. Following recovery oocytes were examined by time-lapse 
microscopy during progression through MI in control or BI 2536-supplemented medium, for 
approximately 16h. (B) Securin-YFP average fluorescence intensity (FI) in control (black) and 
25nM BI 2536-treated (red) oocytes was measured at each time-point and background FI was 
subtracted. The values were normalised relative to that of GVBD (0h), and their mean values at 
each time-point were plotted against time. Securin-YFP degradation is inhibited in the presence 
of BI 2536. Errors bars indicate ±SD; AU, arbitrary units; PBE, polar body extrusion; n, oocyte 
number. (C) Selected DIC, RFP and YFP time-lapse images of a representative control oocyte at 
the indicated time-points. (D) Selected DIC, RFP and YFP time-lapse images of a representative 
25nM BI 2536-treated oocyte at the indicated time-points. Note the absence of efficient securin 
degradation and PBE.  
 81 
4.6.1 BI 2536 inhibits the activation of APC/CCdc20 in MI. 
According to the latter results BI 2536 inhibits the degradation of securin in late 
metaphase of MI, indicating that the APC/C is not efficiently activated. 
However, they do not provide proof that this is mediated by sustained 
activation of the SAC. Could BI 2536 have a SAC-independent inhibitory effect 
on the APC/C? To answer that, it was necessary to find a way to bypass the 
SAC and that was achieved by employing a mutant form of the APC/C 
activator Cdc20, known as Cdc20R132A (Fig 2.2).  According to the currently 
prevalent model of SAC activation, unattached kinetochores cause the 
formation of the mitotic checkpoint complex, a complex comprising the 
checkpoint proteins Mad2, Bub3, BubR1 and Cdc20, which sequesters Cdc20, 
thus inhibiting APC/C from targeting cyclin B and securin for degradation 
(Musacchio and Salmon, 2007). Recent studies have identified the binding 
domain of Cdc20 on Mad2 and a point mutation in that domain (R132A) has 
been shown to allow robust binding to APC/C, but prevent binding with Mad2 
(Zhang and Lees, 2001; Ge et al., 2009). In other words, Cdc20R132A can activate 
the APC/C and promote anaphase without being given the “ok” signal from the 
SAC. 
 
To test the ability of Cdc20R132A to bypass the SAC in oocytes, I asked whether it 
could degrade securin the presence of the drug nocodazole, which activates the 
oocyte SAC by depolymerising microtubules (Wassmann et al., 2003). Fully-
grown prophase-arrested CD1 oocytes were co-injected with mRNA encoding 
securin-YFP, H2B-RFP and wild type Cdc20 (control group) or Cdc20R132A (test 
group) and were imaged by time-lapse microscopy during maturation in 
nocodazole-supplemented media, for approximately 16h (Fig 4.10). Analysis of 
the time-lapse movies showed that, in control oocytes exogenous securin is 
accumulated (Fig 4.10.A/B). This is consistent with sustained activation of the 
oocyte SAC in the presence of nocodazole (Wassmann et al., 2003).  In contrast, 
in Cdc20R132A-injected oocytes, exogenous securin is degraded (Fig 4.10.A/C). 
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Considering that in oocytes injected with Cdc20R132A-encoding mRNA, the 
timing of APC/C activation is unregulated, it would be reasonable to expect 
differences in the kinetics of securin degradation between individual oocytes as 
it could initiate any time during prometaphase of MI. Nevertheless, the results 
indicate that Cdc20R132A is capable of bypassing the SAC to activate APC/C in 
mouse oocytes.  
 
The next step was to use Cdc20R132A to determine whether inhibition of APC/C 
during exit from MI in the presence of BI 2536 was due to sustained activation 
of the SAC. Therefore, fully-grown prophase-arrested CD1 oocytes were co-
injected with mRNA encoding securin-YFP, H2B-RFP and wild-type Cdc20 or 
Cdc20R132A and were monitored by time-lapse microscopy in the presence of 
nocodazole and 25nM BI2536 supplemented medium, for approximately 16h 
(Fig 4.11). As expected, oocytes injected with wild-type Cdc20 accumulated 
exogenous securin (Fig 4.11.A/B) in the presence of nocodazole. Surprisingly, in 
Cdc20R132A-injected oocytes, exogenous securin was also stable, despite the 
ability of Cdc20R132A to override the SAC and activate the APC/C (Fig 4.11.A/C). 
These results indicate that the SAC is not the sole cause of prometaphase arrest 
in the presence of BI 2536. Although we cannot rule out the SAC, it is clear that 
another mechanism, which involves inhibition of the APC/C is in play. 
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Figure 4.10 Cdc20R132A allows degradation of securin in the presence of 
nocodazole. 
(A) Securin-YFP levels of representative oocytes (5 per group) co-injected with mRNA encoding 
securin-YFP, H2B-RFP and Cdc20WT (grey, n=8) or securin-YFP, H2B-RFP and Cdc20R132A (red, 
n=7) and examined by time-lapse microscopy during progression through MI, in nocodazole-
supplemented media. Securin-YFP mean fluorescence intensity (MFI) in oocytes was measured 
at each time-point and background FI was subtracted. The values were normalised relative to 
that of GVBD (0h), and plotted against time. Securin-YFP degradation is inhibited in oocytes 
injected with Cdc20WT in the presence of nocodazole, whereas it is allowed in Cdc20R132A-
injected oocytes. Bold curves indicate oocytes shown in (B) and (C). AU, arbitrary units. (B, C) 
Selected DIC, RFP and YFP time-lapse images of the oocytes whose securin-YFP levels are 
illustrated by bold curves in (A), at the indicated time-points before and after GVBD in hours. 
Note securin-YFP degradation in (C). 
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Figure 4.11 BI 2536 inhibits degradation of securin in Cdc20R132A-injected 
oocytes in the presence of nocodazole. 
(A) Securin-YFP levels of representative oocytes (5 per group) co-injected with mRNA encoding 
securin-YFP, H2B-RFP and Cdc20WT (grey, n=6) or securin-YFP, H2B-RFP and Cdc20R132A (red, 
n=7) and examined by time-lapse microscopy during progression through MI, in medium 
supplemented with nocodazole and 25nM BI 2536. Securin-YFP mean fluorescence intensity 
(MFI) in oocytes was measured at each time-point and background FI was subtracted. The 
values were normalised relative to that of GVBD (0h), and plotted against time. Securin-YFP 
degradation is inhibited even in oocytes injected with Cdc20R132A. Bold curves indicate oocytes 
shown in (B) and (C). AU, arbitrary units. (B, C) Selected DIC, RFP and YFP time-lapse images 
of the oocytes whose securin-YFP levels are illustrated by bold curves in (A), at the indicated 
time-points before and after GVBD in hours. 
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4.6.2 Exogenous cyclin B1 relieves inhibition of securin degradation in the 
presence of BI 2536.  
Based on the latter observations, the effect of Plk1 inhibition on the APC/C is 
not mediated solely by the SAC. To determine whether this is a securin-specific 
effect or if BI 2536-treatment also affects the degradation of other APC/CCdc20 
substrates, we monitored the kinetics of ectopically expressed RFP-tagged 
cyclin B1 during progression through MI in the presence of BI 2536. 
 
Fully-grown prophase-arrested CD1 oocytes were co-injected with mRNA 
encoding cyclin B1-RFP and securin-YFP and were monitored by time-lapse 
microscopy during maturation in control medium or medium supplemented 
with 25nM BI 2536 (Fig 4.12). Analysis of the time-lapse movies showed that in 
control oocytes degradation of exogenous securin and cyclin B1 is initiated at 
4.8h (±1.5h SD) post-GVBD and continues until PBE, which is followed by 
reaccumulation of exogenous securin and cyclin B1 (Fig 4.12.A/B/C). Rather 
expectedly, in BI 2536-treated oocytes, exogenous securin and cyclin B1 do not 
accumulate as much as in controls and their degradation is initiated earlier, at 
2.9h (±1h SD) post-GVBD (Fig 4.12.A/B/D). Moreover, degradation appears less 
abrupt, compared to controls, and continues until it reaches a baseline level 
(about 9h post-GVBD), without leading to anaphase or PBE during the 
experimental time-frame (Fig 4.12.A/B/D). Finally, in contrast to controls, no 
reaccumulation of exogenous securin and cyclin B1 is observed (Fig 
4.12.A/B.D). These data indicate that overexpression of exogenous cyclin B1 
partially relieves inhibition of APC/CCdc20 in the presence of BI 2536.  
 
Additional experiments involving microinjection of exogenous mRNA 
encoding a mutant cyclin B1, which does not bind to Cdk1 [namely, cyclin 
B1Y170A (Bentley et al., 2007)], would allow us to test the hypothesis that the 
partial rescue was due to increased Cdk1 activity associated with 
overexpression of cyclin B1. 
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Figure 4.12 Exogenous cyclin B1 relieves inhibition of securin degradation in 
the presence of BI 2536. 
(A) Cyclin B1-RFP and (B) securin-YFP levels of representative oocytes (5 per group) co-injected 
with mRNA encoding cyclin B1-RFP and securin-YFP and examined by time-lapse microscopy 
during progression through MI in control medium (grey) or medium supplemented with 25nM 
BI 2536 (red). Cyclin B1-RFP and securin-YFP mean fluorescence intensities (MFI) in oocytes 
were measured at each time-point and background FI was subtracted. The values were 
normalised relative to that of GVBD (0h), and plotted against time. Securin-YFP degradation is 
rescued in oocytes co-injected with cyclin B1-RFP in the presence of BI 2536. Bold curves 
indicate oocytes shown in (C) and (D). AU, arbitrary units; n, number of oocytes. (B, C) Selected 
DIC, RFP and YFP time-lapse images of the oocytes whose cyclin B1-RFP and securin-YFP 
levels are illustrated by bold curves in (A) and (B), at the indicated time-points before and after 
GVBD in hours. 
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4.7 Discussion 
In this chapter I have aimed to perform a functional analysis of Plk1 in 
mammalian oocytes. To achieve that I have used BI 2536, a chemical inhibitor of 
Plk1, in various concentrations and in combination with indirect immuno-
fluorescence staining and live-cell imaging of oocytes injected with mRNAs 
encoding fluorescent proteins. I have provided evidence that Plk1 is recruited 
to the kinetochore region upon release into prometaphase and its recruitment is 
unaffected by a low dose of BI 2536. Inhibition of Plk1 kinase activity by BI 2536 
did not affect the timing of entry into prometaphase of MI, but prevented 
initiation of anaphase of MI in a dose-dependent manner. Oocytes that were 
arrested in prometaphase of MI in the presence of BI 2536 did not undergo 
anaphase, were characterised by increased distance between sister centromeres 
and exhibited severe chromosome misalignment defects. Finally, I have shown 
that BI 2536 inhibits securin degradation and the data indicate that this occurs 
by a SAC-independent mechanism. 
4.7.1 Plk1 is recruited to the kinetochore of meiotic chromosomes 
The association of Plk1 with chromosomes has not received much attention in 
published studies of the subcellular localisation of the protein during meiosis. 
Based on my knowledge, currently only a single publication has provided 
evidence that Plk1 localises to the kinetochore of mouse oocytes during 
prometaphase of MI (Kouznetsova et al., 2007). The localisation of Plk1 
described here on the meiotic chromosomes suggests that it is associated with 
the kinetochore region during meiotic maturation, where it persists until late 
prometaphase of MI (Fig 4.2). I have also found that Plk1 localised on 
kinetochores of Met II arrested oocytes, albeit at significantly reduced levels 
compared to MI. The Kt-localisation of Plk1 described here is consistent with 
previous findings in somatic cells (Arnaud et al., 1998; Sumara et al., 2004; 
Lenart et al., 2007). The presence of Plk1 on this region of the chromosome 
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during meiotic maturation suggests that it is required for accurate kinetochore 
function as in mitosis [reviewed by (Petronczki et al., 2008)]. 
Furthermore, the data presented here indicate that inhibition of Plk1 kinase 
activity by BI 2536 did not prevent its kinetochore recruitment during MI when 
the concentrations of 6.25nM (Fig 4.3) and 25nM (data not shown) were applied. 
This contradicts findings in mitosis where Plk1 activity is required for its 
accumulation at kinetochores (Lenart et al., 2007; Santamaria et al., 2007), 
suggesting that this mechanism may not be essential in meiosis. However, we 
cannot exclude the possibility of residual Plk1 activity as previous mitotic 
studies have applied a 100nM concentration of BI 2536 to reach their 
conclusions (Lenart et al., 2007). Further experimentation with higher 
concentrations of BI 2536 could provide an answer regarding the necessity of 
Plk1 activity for the enzyme’s kinetochore recruitment in meiosis. However, 
considering the greater volume of an oocyte (~ 4x105 m3) compared with that 
of a HeLa cell (~ 2x103 m3) it is conceivable that a concentration of BI 2536 
higher than 100nM might be required to achieve total Plk1-inhibition, thereby 
posing the risk of inhibiting other Plks with unpredictable effects. 
 
4.7.2 BI 2536 does not affect the timing of entry into prometaphase of MI, but 
prevents initiation of anaphase of MI in a dose-dependent manner 
A number of studies have implicated Plk1 in promoting mitotic entry in 
vertebrate cells by activating Cdk1-cyclin B (Toyoshima-Morimoto et al., 2001; 
Toyoshima-Morimoto et al., 2002; Jackman et al., 2003; Watanabe et al., 2004). 
However, Plk1 activity does not appear to be essential for mitotic entry, as its 
inhibition will only delay prophase and nuclear envelope breakdown (NEBD) 
(Lenart et al., 2007). Similar observations have been made in mouse and rat 
oocyte studies; inhibition of Plk1 activity either by Plk1 antibody microinjection 
(Tong et al., 2002; Fan et al., 2003) or by BI 2536 (Vanderheyden et al., 2009) 
caused a delay in resumption of meiosis I and GVBD onset and prevented the 
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extrusion of the first polar body. To determine the efficiency of different BI 2536 
concentrations on oocyte maturation I have examined GVBD timing and PB 
extrusion. The results show that none of the tested BI 2536 concentrations 
causes a significant delay in GVBD (Fig 4.4A), consistent with previous 
observations, where concentrations of BI 2536 below 100nM had no effect on 
meiosis I resumption (Vanderheyden et al., 2009). Prolonged exposure to BI 
2536 in order to eliminate the possibility of a delayed action also had no effect 
on GVBD timings (Fig 4.4B). However, BI 2536 has a dose-dependent effect on 
the ability of oocytes to exit MI; the extrusion of the first PB is abrogated by 
25nM of BI 2536, while significant inhibition is observed even at a 6.25nM 
concentration (Fig 4.5). Overall these results indicate that in mouse oocytes, 
Plk1 activity is not essential for meiosis resumption, but is essential for MI 
completion and BI 2536 can effectively and rapidly inhibit it. 
4.7.3 BI 2536 inhibits anaphase of MI, disrupts sister-centromere integrity and 
promotes misalignment of bivalents. 
Analysis of chromosome spreads of oocytes arrested during prometaphase of 
MI in the presence of BI 2536 revealed the presence of intact bivalents (Fig 4.6) 
indicating that BI 2536 treatment induces arrest in prometaphase. Previous 
studies in somatic cells have shown that BI 2536 leads to arrest in prometaphase 
due to activation of the SAC (Lenart et al., 2007) and that Plk1 is involved in the 
establishment of correct Kt-Mt attachments [reviewed in (Petronczki et al., 
2008)]. Could BI 2536-treated oocytes arrest in prometaphase I due to failure to 
establish monopolar Kt-Mt attachments of sister centromeres? Indeed, I have 
shown here that sister centromeres in BI 2536-treated oocytes lose their tight 
apposition (Fig 4.7), which has been proposed to facilitate the establishment of 
monopolar Kt-Mt attachments of sister chromatids (Hauf and Watanabe, 2004; 
Brar and Amon, 2008; Sakuno and Watanabe, 2009). Moreover, at 25nM of BI 
2536 the majority (~78% - Fig 4.8C/D) of oocytes exhibited bivalent 
misalignment and more than half (~57% - Fig 4.8D) had at least one mono-
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oriented bivalent (Fig 4.8.E/”Failed”). Finally, although I saw no convincing 
evidence of bipolar attachment of sisters, it is impossible to rule it out based on 
the immuno-labeling experiments shown here. Overall, these results 
demonstrate that bivalents do not congress in the presence of BI 2536, 
indicating that Plk1 kinase activity is required for congression in MI. 
 
Taken together, our data suggest that Plk1 activity is essential for the 
establishment of stable microtubule- kinetochore attachments in MI. This is 
consistent with previous observations in somatic cells [reviewed in (Petronczki 
et al., 2008)]. It is possible that kinetochores can be captured by microtubules in 
the absence of Plk1 activity, but these attachments may not be stable and proper 
K-fibers may therefore not be formed. Previous studies in mammalian somatic 
cells (Ditchfield et al., 2003; Lampson and Kapoor, 2005) and oocytes (Homer et 
al., 2009b) have shown that depletion of BubR1 also causes defects in 
microtubule-kinetochore attachments. BubR1 phosphorylation is essential for 
the stability of Kt-Mt interactions and it is Plk1-dependent (Elowe et al., 2007; 
Suijkerbuijk et al., 2012). Moreover, BI 2536-treated cells have been shown to 
lack the hyper-phosphorylated form of BubR1 (Lenart et al., 2007). Thus, as in 
mitosis, meiotic Plk1 activity might contribute to K-fiber formation by 
phosphorylation of BubR1 at kinetochores during MI.  
 
On the basis of these findings, we propose that BI 2536 impairs the ability to 
establish and maintain monopolar sister kinetochore-microtubule attachments. 
 
4.7.4 Plk1 prevents degradation of exogenous securin and is required for 
efficient activation of APC/Ccdc20 in MI 
Previous studies in mouse oocytes have shown that the target of the SAC is 
APC/Ccdc20 activation and subsequent degradation of securin and cyclin B1, 
which are essential for completion of MI. Here, we have shown that BI 2536-
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treated oocytes arrest in late prometaphase of MI (Fig 4.6) and that exogenous 
securin is not efficiently degraded in these oocytes (Fig 4.9). These data 
suggested the possibility that BI 2536-treated oocytes arrest in prometaphase I 
because of SAC activation. 
 
To further test this possibility, we employed mRNA encoding Cdc20R132A, which 
can over-ride the SAC (Fig 4.10A/C). When we filmed oocytes expressing 
exogenous Cdc20WT and securin-YFP incubated in the presence of BI 2536 and 
nocodazole, which causes sustained activation of the SAC in oocytes (Brunet et 
al., 2003; Wassmann et al., 2003; Homer et al., 2005a; Kudo et al., 2006), all 
oocytes arrested in prometaphase I and exhibited accumulation of exogenous 
securin (Fig 4.11A/B). Similarly, we observed prometaphase I arrest and 
exogenous securin accumulation in oocytes expressing exogenous Cdc20R132A 
and incubated in nocodazole and BI 2536 (Fig 4.11A/C). These data indicate that 
inhibition of APC/C in the presence of BI 2536 is SAC –independent. This 
stands in contrast to what has been recently shown in mammalian mitosis 
(Lenart et al., 2007), but is consistent with older reports that in the absence of 
Plx1 activity some APC/C targets are not degraded by the proteasome 
(Descombes and Nigg, 1998). 
 
By what mechanism might Plk1 inhibit the APC/C?  In support of a direct effect 
on core APC/C subunits, it has been reported that mouse Plk1 phosphorylates 
subunits of the APC/C (Kotani et al., 1998). Also, the finding that overexpression 
of cyclin B1 partly relieves inhibition of APC/CCdc20 in the presence of BI 2536 
(Fig 4.12), suggests that Cdk1 and Plk1 may act synergistically to promote 
efficient activation of the APC/C during exit form MI. In support of this, 
subsequent experiments in the lab have shown that a mutant cyclin B1 (Y170A), 
which does not bind to Cdk1 (Bentley et al., 2007), does not rescue the inhibitory 
effect of Plk1 on securin degradation (data not shown), indicating that 
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activation of Cdk1 is necessary for rescuing the APC/C inhibition in the 
presence of BI 2536.  
 
An alternative or additional possibility is that Plk1 is also required to deactivate 
an inhibitor of the APC/C in oocytes. This scenario might actually involve Emi1, 
which is known to inhibit APC/C in both mitosis (Reimann et al., 2001a; 
Reimann et al., 2001b) and meiosis (Marangos et al., 2007) . During mitotic 
prometaphase, Plk1 phosphorylates Emi1, thereby leading to its recognition by 
the SCF ubiquitin ligase and its subsequent degradation by the proteasome 
(Guardavaccaro et al., 2003; Margottin-Goguet et al., 2003; Hansen et al., 2004; 
Moshe et al., 2004). Similarly, in meiosis Emi1 is degraded soon after GVBD 
(Marangos et al., 2007) presumably to allow APCCdc20 activation, once the SAC 
has been satisfied, which is necessary to coordinate the destruction of securin 
and cyclin B and allow exit from MI. Although the idea that Emi1 inhibits 
APC/Ccdc20 has been previously contended (Di Fiore and Pines, 2007), a recent 
study has re-ignited the debate (Moshe et al., 2011). Based on the above, I 
propose that the observed APC/CCdc20 inactivation/inhibition during MI in the 
presence of BI 2536 is probably due to insufficient phosphorylation/activation of 
APC/C subunits, combined with insufficient degradation or accumulation of 
Emi1. Additional experimentation involving microinjection of oocytes with 
fluorescently-tagged Emi1 mRNA, to assess Emi1 kinetics in the presence of BI 
2536, and non-degradable Emi1, to assess its effect on APC/Ccdc20, would allow 
further evaluation of this hypothesis. 
 
In summary, the findings presented in this chapter indicate that Plk1 is required 
for activation of the APC/C during exit from prometaphase of MI. Inhibition of 
Plk1 also induced congression defects, and it is possible that severely 
misaligned bivalents induce sustained activation of the SAC. However, the 
findings indicate that inhibition of the APC/C  in the presence of BI 2536 is not 
solely due to SAC and raise the possibility that phosphorylation of APC/C core 
 93 
subunits by Plk1 is required for its efficient activation. To assess SAC activation 
in the presence of BI 2536 future experimentation should examine for the 
presence of Mad2 at the centromere of metaphase I arrested oocytes, which is a 
clear indication of Kt-Mt attachment defects (Wassmann et al., 2003; Homer et 
al., 2005a). Finally, the experiments described in section 4.6.1 should also be 
repeated in the absence of nocodazole as an additional control to further 
strengthen our conclusion that inhibition of APC/C in the presence of BI 2536 is 
SAC –independent.  
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 . Plk1 is required for stepwise removal of Chapter 5
cohesin in mouse meiosis 
5.1 Introduction 
The findings of the previous chapter indicate that Plk1 is required for efficient 
activation of the APC/C during exit from MI. However, a proportion of oocytes 
did produce polar bodies in lower concentrations (≤12.5nM) of BI 2536. This 
provided an assay to investigate possible functions of Plk1 in mediating 
chromosome segregation during MI.   
 
In budding yeast, the Plk1 homolog, Cdc5, phosphorylates and primes Rec8 for 
cleavage by separase and is required for proper kinetochore orientation during 
MI (Clyne et al., 2003; Lee and Amon, 2003; Brar et al., 2006). However, a recent 
study suggests that Cdc5 has little, if any, role in promoting Rec8 cleavage and 
attributes this role to Casein Kinase 1 (Katis et al., 2010; Rumpf et al., 2010). It is 
not currently known if Plk1 regulates these processes in mouse oocytes. 
However, a previous study suggested that Plk1 phosphorylation is essential for 
Rec8 cleavage by separase in vitro (Kudo et al., 2009). 
 
While the requirement for Plk1-mediated phosphorylation to prime Rec8 for 
cleavage by separase is controversial, Plk1 has a well-established function in 
removing the bulk of arm cohesin during prophase and prometaphase of 
vertebrate somatic cells, via a process known as the “prophase 
pathway”(Losada et al., 1998; Sumara et al., 2002). This process does not require 
the cleavage of cohesin by separase, as cohesin dissociation is achieved through 
its phosphorylation by Plk1, mediated by Aurora B (Hauf et al., 2005). My 
hypothesis was that a similar process might also occur during meiotic 
prophase. In other words, Plk1 could be involved in cohesin removal through a 
mechanism that would be the meiotic equivalent of the prophase pathway. 
Given that mammalian oocytes remain arrested in prophase of MI for an 
extended time period, prior to being released into prometaphase I, it is 
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conceivable that prolonged exposure to such a mechanism could be another 
factor contributing to the observed depletion of chromosome-associated cohesin 
in old oocytes. 
 
In this chapter, I investigate the interplay between Plk1 activity and cohesin in 
mammalian oocytes during MI. I also investigate the role of Plk1 on 
chromosome segregation in mouse oocytes by analyzing oocytes that formed 
polar bodies in the presence of BI 2536. To achieve accurate observations I have 
used oocytes from the transgenic Rec8-myc mouse strain (Kudo et al., 2006) 
where cohesin-related measurements were necessary.  
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5.2 Securin profile of oocytes that exit MI in the precence of BI 2536 
As described in the previous chapter BI 2536 inhibits anaphase of MI in a dose-
dependent manner (Section 4.5). At low concentrations (6.25 and 12.5 nM) a 
subset of oocytes exit MI and extrude the first polar body. Having established 
that BI 2536 leads to prometaphase I arrest by inhibiting securin degradation , I 
hypothesised that in the case of oocytes that exit MI, securin degradation ,and 
therefore anaphase, would most probably be delayed compared to control 
conditions.  To test this hypothesis, fully-grown prophase-arrested CD1 oocytes 
were co-injected with mRNA encoding securin-YFP and H2B-RFP and were 
monitored by time-lapse microscopy during incubation in control or 6.25nM BI 
2536-supplemented medium, for approximately 16h (Fig 5.1.A). Analysis of the 
time-lapse movies showed that in control oocytes exogenous securin starts 
being degraded about 6h post-GVBD and anaphase and subsequent polar body 
extrusion (PBE) occur at 8.3h (±1.15h SD) post-GVBD, followed by 
reaccumulation of securin (Fig 5.1.A/B). In contrast, in BI 2536-treated oocytes, 
exogenous securin degradation is delayed (Fig 5.1.A/C), and the onset of 
anaphase and PBE occur at 9.7h (±0.78h SD) post-GVBD (Fig 5.1.C).  As in 
control oocytes, securin-YFP reaccumulated after PBE (Fig 5.1.C). 
 
Interestingly, polar body formation was perturbed in BI 2536-treated oocytes. 
Abnormalities included production of large polar bodies (observed in 25% of 
oocytes), suggesting improper positioning of the meiotic spindle at the oocyte 
cortex. In addtion, a proportion of oocytes (58%) showed polar body 
fragmentation, and failed abscission (17%). The latter phenotypes  may reflect a 
requirement for Plk1 kinase activity for correct cytokinesis, which is consistent 
with previous observations in somatic cells (Brennan et al.; Burkard et al., 2007; 
Petronczki et al., 2007; Santamaria et al., 2007).  
 
Overall, these results indicate that Plk1 kinase activity is required for timely 
degradation of securin and successful cytokinesis in MI. 
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Figure 5.1 Degradation of securin-YFP during exit from MI in the presence of 
low concentrations (6.25 nM) of BI 2536  
(A) Securin-YFP levels of representative oocytes (3 per group) co-injected with mRNA encoding 
securin-YFP and H2B-RFP and examined by time-lapse microscopy during incubation in 
control medium (grey, n=15) or in medium supplemented with 6.25nM BI 2536 (red, n=12). 
Securin-YFP mean fluorescence intensity (MFI) in oocytes was measured at each time-point and 
background FI was subtracted. The values were normalised relative to that of GVBD (0hr), and 
plotted against time. Securin-YFP degradation is delayed in the presence of BI 2536. Bold curves 
indicate oocytes shown in (B) and (C). AU, arbitrary units. (B, C) Selected DIC, RFP and YFP 
time-lapse images of the oocytes whose securin-YFP levels are illustrated by bold curves in (A), 
at the indicated time-points before and after GVBD in hours. Note the large polar body in (C) 
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5.3 BI 2536 promotes separation sister chromatids in a dose-dependent 
manner 
The next step was to identify any possible effects that BI 2536 might have on 
chromosome segregation during meiosis I. To do that I prepared chromosome 
spreads of the oocytes that produced polar bodies and immunolabelled the 
centromeres for CREST.  
 
Surprisingly, I found that  BI 2536 induced premature separation of sisters (Fig 
5.2).  Concentration as low as 3nM BI2536 resulted in precocious separaton of 
sisters in the majority (90%) of oocytes compared with 8% of control oocytes 
(P<0.05) (Fig 5.2.B). The proportion of dyads showing premature separation of 
sisters increased in a dose-dependent manner, ranging from 9.3% ( 7.2%) in 
3nM to 100% in 6.25nM  and 12.5 nM (Fig 5.2.C).  
 
Overall, these data indicate that Plk1 kinase activity is required to protect 
centromeric cohesion and that this function is highly sensitive to inhibition by 
BI 2536. 
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Figure 5.2 Sister chromatid separation in the presence of BI 2536 
(A) Representative images showing DNA and CREST staining of chromosome spreads 
prepared from control and 12.5nM BI2536-treated oocytes, after exit from MI. Scale bars 
represent 10μm. Notice the separation of sister chromatids in BI 2536-treated oocytes. (B) The 
graph shows the percentages of oocytes exhibit premature sister-chromatid separation, 
following MI exit, after incubation in increasing concentrations of BI 2536: Control, 8% (±8% 
SD); 3nM BI2536, 90% (±13% SD), 4nM BI 2536, 95% (±7% SD); 6.25nM BI 2536, 100% (±0% SD); 
12.5nM BI 2536, 100% (±0% SD). Notably, 6.25nM of BI 2536 are adequate to produce a fully 
penetrant effect. (C) The graph shows the number of separated sister chromatids in oocytes that 
exit MI, after incubation in increasing concentrations of BI 2536: Control, 0.3% (±0.87% SD); 3nM 
BI2536, 9.3% (±7.2% SD), 4nM BI 2536, 14.4% (±7.8% SD); 6.25nM BI 2536, 21.5% (±9% SD); 
12.5nM BI 2536, 26.2% (±2.2% SD). BI 2536 appears to promote premature separation of sisters 
in a dose-dependent manner. Red lines indicate mean values and asterisks (*) indicate groups 
whose mean values show significant difference (P<0.05). 
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5.4 Post-PBE treatment with BI 2536 does induce premature separation of 
sister chromatids 
In order to investigate whether the observed premature separation of sister 
chromatids caused by BI 2536 is due to an effect that occurs prior to metaphase 
II (MetII) arrest, I decided to expose oocytes to BI 2536 after the extrusion of the 
first polar body. Fully-grown prophase-arrested oocytes from CD1 mice were 
harvested and were cultured in control medium; those that had undergone 
GVBD within two hours were selected for further maturation. From the latter 
group, those that had successfully arrested at MetII after nine hours were 
transferred into medium supplemented with 6.25nM or 12.5nM of BI 2536. The 
oocytes were cultured for a further 10-12 hours in the presence of the inhibitor, 
before being used to produce chromosome spreads, which were 
immunolabeled for CREST. 
 
In contrast to MI oocytes, exposure of MetII-stage oocytes to BI 2536 did not 
result in an increased incidence of single sisters (Fig 5.3). In particular, 
concentrations of 6.25nM and 12.5nM of BI 2536 did not have a significant effect 
either on the number of oocytes with separated sisters (P>0.05) or on the 
number of dyads showing premature separation of sisters per oocyte (P>0.05) 
compared with control oocytes .  
 
These results indicate that PLK1 is likely to be involved in preventing 
separation of sisters during anaphase of MI.  
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Figure 5.3 BI 2536 does not induce premature separation of sisters during 
MetII arrest  
 (A) Representative images showing DNA and CREST staining of chromosome spreads 
prepared from control and 6.25nM or 12.5nM BI2536-treated oocytes. BI 2536 was applied after 
PBE (MetII-arrest). Chromosomes surrounded by white boxes are shown in the enlarged 
images. Scale bars represent 10μm. (B) The graph shows the percentages of oocytes that exhibit 
premature sister-chromatid separation at MetII-arrest, after post-PBE incubation in increasing 
concentrations of BI 2536: Control, 12% (±10% SD); 6.25nM BI 2536, 22% (±5% SD); 12.5nM BI 
2536, 19% (±8.9% SD). BI 2536 did not have a significant effect on the number of oocytes with 
separated sisters (P>0.05) (C) The graph shows the number of separated sister chromatids in 
oocytes exposed to increasing concentrations of BI 2536 after PBE: Control, 0.31 (±0.89 SD); 
6.25nM BI 2536, 0.63 (±1.19 SD); 12.5nM BI 2536, 0.5 (±1.08 SD). BI 2536 does not appear to 
compromise sister chromatid integrity at the concentrations used (P>0.05). Red lines indicate 
mean values. 
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5.5 Centromeric cohesin is not depleted during in BI 2536-treated oocytes. 
The presence of single sisters in oocytes which exit MI in the presence of BI 
2536, gave ground to the hypothesis that centromeric cohesin might become 
depleted before the onset of anaphase I. To test this idea, I used the transgenic 
Rec8-myc mouse strain, where wild-type Rec8 has been replaced by a C-
terminally 9x Myc-tagged wild-type Rec8 (Rec8-Myc), which can be specifically 
immunolabeled with an anti-myc antibody (Kudo et al., 2009). In order to 
examine for a possible disruption in sister centromere integrity, the inter-
centromeric distances and the levels of centromeric cohesin were measured and 
compared between late prometaphase (GVBD+6h) control oocytes and oocytes 
matured in medium supplemented with 6.25nM or 12.5nM BI 2536 (Fig 5.4). 
Consistent with my previous observation in oocytes from the CD1 mouse strain 
(Section 4.5.1), I found that inter-centromere distances significantly (P < 0.0001) 
increased in BI 2536 treated oocytes compared to control oocytes (Fig 5.4.D). For 
calculating centromeric Rec8:CREST fluorescence intensity ratios, following 
background FI subtraction, a square region of fixed  area (5.4.Ea) was centred 
on the centromere to be measured and the Rec8 and CREST intensities were 
measured in the same region. Surprisingly, statistical analysis of the results 
showed a significant increase in the levels of centromeric Rec8-Myc in the 
presence of BI 2536.  
 
These results indicate that premature sister separation in the presence of BI 2536 
is not due to depletion of centromeric cohesin during progression through 
prometaphase I. 
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Figure 5.4 Effect of BI 2536 on inter-centromere distance and centromeric 
cohesin in Rec8-myc oocytes 
Representative images showing DNA, Rec8, and CREST staining of chromosome spreads 
prepared during late prometaphase (GVBD + 6 hr) of MI oocytes from Rec8-myc mice incubated 
in (A) control media and media supplemented with (B) 6.25nM or (C) 12.5nM BI 2536. 
Chromosomes surrounded by white boxes are shown in the enlarged images.   Scale bars 
represent 10μm. (D) Frequency distribution of the distance between sister centromeres, 
measured from the CREST foci in control (mean= 0.33±0.12μm; n = 184 centromeres; six oocytes 
from three mice), 6.25nM BI 2536-treated (mean= 0.41±0.13μm; n = 183 centromeres; six oocytes 
from three mice) and 12.5nM BI 2536-treated (mean= 0.42±0.13μm; n= 191 centromeres; six 
oocytes from three mice) oocytes, showing a significantly greater mean distance in the BI 2536-
treared compared to control oocytes (P < 0.0001). (E) Graph showing Rec8: CREST fluorescence 
intensity (FI) ratios at the centromeres (a) of oocytes in (A) (n = 302 centromeres; eight oocytes 
from three mice), in (B) (n = 307 centromeres; eight oocytes from three mice) and in (C) (n = 333 
centromeres; eight oocytes from three mice). Red lines indicate mean values and asterisks (*) 
indicate groups whose mean values show significant difference (P<0.0001).  
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5.6 BI 2536 compromises the centromeric localisation of Sgo2-PP2A at late 
prometaphase of MI 
In light of the finding that centromeric cohesin is not depleted before the onset 
of anaphase I, I next asked whether premature separation of sisters might be 
due to disruption of the mechanisms responsible for protecting centromeric 
cohesin during anaphase of MI. As discussed previously, Sgo2 and PP2A are 
known to protect centromeric cohesion in mouse oocytes during anaphase of 
MI (Riedel et al., 2006; Lee et al., 2008; Llano et al., 2008). I therefore investigated 
whether recruitment of these proteins to centromeres is disrupted in the 
presence of BI 2536. 
 
Fully-grown prophase-arrested oocytes from CD1 mice were harvested and 
were allowed to mature in control medium or medium supplemented with 
6.25nM BI 2536. Chromosome spreads were produced using oocytes at late 
prometaphase of MI (GVBD+7h) and were immunolabeled for CREST, Sgo2 
and PP2A. Subsequent image analysis revealed what could be described as a 
diffused and “off-centred” localisation of both Sgo2 and PP2A on the sister 
centromeres of BI 2536-treated oocytes (Fig 5.5.B) compared to control oocytes 
(Fig 5.5.A). In addition, BI 2536-treated oocytes also appear to have higher 
levels of chromosome-associated PP2A (Fig 5.5.B) compared to controls. Sister 
centromeres were categorised into three groups; sister centromeres where Sgo2-
PP2A colocalised centrally between centromeres (Fig 5.5.A1), others where the 
Sgo2-PP2A signal was displaced from the centre of the centromeres (Fig 5.5.B3) 
and finally some, where characterisation was not possible due to doubt and/or 
bad IF staining. Classification of numerous sister centromere pairs based on the 
“Central” or “Off-Centred” localisation of Sgo2-PP2A showed that there were 
significant (P<0.001) differences between control and BI 2536-treated oocytes 
(Fig. 5.5.C), with the “Off-Centred” configuration becoming prevalent in the 
presence of BI 2536. For example, in control oocytes 85% of late prometaphase 
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centromeres had a centrally localised Sgo2-PP2A signal, whereas the respective 
proportion in BI 2536-treated oocytes was just 33%.  
 
These results indicate that the centromeric localisation of Sgo2 and PP2A, which 
is required for the maintenance of centromeric sister chromatid cohesion until 
the onset of anaphase II,  is disrupted in oocytes in the presence of BI 2536. 
Based on these findings, I propose that centromeric cohesin might be partially 
“exposed” to the effect of seperase, and consequently cleaved, during anaphase 
I, thus leading to precocious sister-chromatid separation.  
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Figure 5.5 The effect of BI 2536 on centromeric localisation of Sgo2-PP2A in 
late prometaphase of MI 
Representative images showing DNA, Sgo2, PP2A and CREST staining of chromosome spreads 
prepared during late prometaphase (GVBD + 7 hr) of oocytes cultured in (A) control medium 
(23 oocytes from 3 mice) and (B) in medium supplemented with 6.25nM BI 2536 (16 oocytes 
from 3 mice). Enlarged images show four numbered representative examples of sister 
centromeres. Notice the diffused and “off-centred” localisation of both Sgo2 and PP2A on the 
sister centromeres of BI 2536-treated oocytes compared to control oocytes. BI 2536-treated 
oocytes also appear to have higher levels of chromosome-associated PP2A. (C) Graph shows the 
proportions of centromeres in control (n = 400 centromeres; 10 oocytes from three mice) and BI 
2536-treated (n = 440 centromeres; 11 oocytes from three mice) oocytes showing “Central” 
(e.g.A1), “Off-centred” (e.g. B3), and “Unclassified” localisation of Sgo2-PP2A. The proportion 
of sister centromeres with “Central” localisation of Sgo2-PP2A was significantly (P < 0.001) 
reduced in BI 2536-treated oocytes, whereas the proportion of “Off-Centred” Sgo2-PP2A foci 
was significantly (P < 0.001) higher compared to control oocytes. Scale bars represent 10μm.  
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5.7 BI 2536 does not affect the levels of chromosome-associated cohesin 
during prometaphase of MI. 
The finding that centromeric cohesin is increased in the presence of BI 2536 (Fig 
5.4), raised the possibility that some cohesin might be removed by a Plk1-
dependent mechanism such as a meiotic equivalent of the Plk1-dependent 
prophase pathway. However, in vertebrate cells, the prophase pathway targets 
arm cohesin rather than centromeric cohesin (Sumara et al., 2002; Hauf et al., 
2005) and as shown in section 5.4, the scope for quantitative analysis was 
limited to centromere-associated cohesin.  I therefore asked what is the effect of 
BI 2536 on arm cohesin in mouse oocytes.  
 
In preliminary experiments to identify a suitable “house-keeping” target to 
improve quantification of arm-associated cohesin, TO-PRO-3, a sequence-
independent DNA stain, which binds specifically and stoichiometrically to the 
sugar phosphate back bone (Bink et al., 2001; Ploeger et al., 2008) was used (data 
not shown). Overall, TO-PRO-3 gave promising results in prometaphase 
oocytes, however, the staining pattern in BI 2536-treated oocytes was less 
reproducible and unfortunately this approach was abandoned.  
 
Measurement of arm cohesin is also complicated by the fact that chromosomes 
become hyper-condensed in the presence of BI 2536. Therefore, although a first 
look at the IF signal of arm-associated cohesin in BI 2536-treated oocytes gives 
the impression that it is brighter compared to controls, implying a role of Plk1 
in the removal of arm cohesin, it could also be an optical artifact due to 
chromatin hyper-condensation. To overcome this difficulty, I decided to 
investigate the effect of BI 2536 on chromosome arm-associated cohesin levels 
in aged oocytes. The rationale behind that decision was that the age-associated 
depletion of cohesin would allow me to distinguish a possible increase in its 
levels in the presence of BI 2536.  
 108 
To test this idea, fully-grown prophase-arrested oocytes from 12-months old 
Rec8-myc mice were harvested and were allowed to mature in control medium 
or medium supplemented with 12.5nM BI 2536. Chromosome spreads were 
produced using oocytes at late prometaphase of MI (GVBD+6h) and were 
immunolabeled for CREST, and Rec8-myc (Fig 5.6A/B/C). Subsequent image 
analysis revealed that consistent with our previous observations (Lister et al., 
2010) Rec8 is significantly depleted in oocytes of aged mice (Fig 5.6B/D). 
However, only a slight and not particularly convincing increase was apparent 
in the levels of chromosome associated Rec8 in BI 2536-treated oocytes 
compared to control oocytes (Fig 5.6C/D).  
 
These results suggest that in mouse oocytes arm-cohesin is generally resistant 
to removal by a Plk1-dependent pathway during progression through MI. 
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Figure 5.6 The effect of BI 2536 on chromosome-associated cohesin levels in 
late prometaphase I 
Representative images showing DNA, Rec8, and CREST staining of chromosome spreads 
prepared during late prometaphase of MI (GVBD + 6 hr) of oocytes from (A) 8-weeks-old Rec8-
myc mice, cultured in control media, (B) 12-months-old Rec8-myc mice, cultured in control 
media and (C) 12-months-old Rec8-myc mice, cultured in media supplemented with 12.5nM BI 
2536. Chromosomes surrounded by white boxes are shown in the enlarged images. Notice the 
reduced Rec8 levels on chromosomes of oocytes from 8-weeks-old compared to 12-months-old 
mice. BI 2536-treated oocytes appear to have higher levels of chromosome-associated cohesin. 
Scale bars represent 10μm. (D) 3D surface plots of (A/B/C) showing higher Rec8 fluorescence 
intensity on chromosomes of 8-weeks-old compared with 12-month-old oocytes and a slight 
increase in Rec8 fluorescence intensity on chromosomes of 12-month-old control compared with 
12-month-old BI 2536-treated oocytes.  
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5.8 Discussion 
In this chapter I aimed to investigate the role of Plk1 in regulating chromosome 
segregation and cohesin removal during MI in mouse oocytes. I have provided 
evidence that Plk1 kinase activity is required for timely degradation of securin 
and successful cytokinesis in MI. My findings also indicate that Plk1 is required 
for the crucial meiotic function of protecting centromeric cohesin during MI, 
most likely through an effect on Sgo2-PP2A localisation.  However, I found 
that, in contrast  to its role in somatic cells (Sumara et al., 2002; Hauf et al., 2005), 
Plk1 does not appear to play a major role in removing cohesin before the onset 
of anaphase.  This indicates that meiotic cohesin is largely resistant to removal 
by the propahse pathway.   
5.8.1 The role of Plk1 in the protection of centromeric cohesion 
To date most research has focused on the role of Plk1 and other Plks in the 
phosphorylation events that either directly promote cohesin dissociation 
(Sumara et al., 2002; Hauf et al., 2005) or prime cohesin for cleavage by separase 
(Lee and Amon, 2003; Kudo et al., 2009; Katis et al., 2010). Here, for the first time 
I present evidence that Plk1 kinase function is crucial for the protection of 
centromeric cohesin and thus its stepwise removal during mouse meiosis. 
 
5.8.1.1 Effect of low concentrations of BI2536 on exit form MI 
To study Plk1 function in regulating events during exit from MI, I took 
advanatage of the fact that a subset of ocytes produced polar bodies in the 
presence of low concentrations (≤12.5nM) of BI2536. My findings indicate a 
delay in securin degradation in the presence of BI 2536 (Fig 5.1). This is 
consistent with the findings I presented in Chapter 4, that Plk1 is required for 
APC/C activation.  
 
Notably, polar body extrusion was also massively perturbed in the presence of 
BI 2536, with oocytes extruding fragmented and occasionally very large (Fig 
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5.1.C) polar bodies. Failed abscission attempts were also observed. This is 
consistent with observations in mitosis, where exposure of HeLa cells to BI 2536 
during anaphase has been shown to block the ingression of the cleavage furrow 
resulting in cytokinesis failure (Brennan et al., 2007a; Petronczki et al., 2007). 
 
5.8.1.2 BI 2536 promotes premature separation of  sisters in a dose-dependent manner 
In control MetII-arrested oocytes, dyads (pairs of sister chromatids) were 
predominantly observed (Fig 5.2A), albeit approximately 12% of the oocytes 
(Fig 5.2B) exhibited 2-4 separated sisters (Fig 5.2C), presumably due to 
mechanical stress during chromosome spreading. In striking contrast, however, 
oocytes that developed to MetII in the presence of BI 2536 showed a marked 
prevalence of separated single chromatids (Fig 5.2A). BI 2536-treated oocytes 
exhibited a mixture of single chromatids and intact dyads at MetII stage (Fig 
5.2A), with the number of single sisters increasing with higher concentrations of 
BI 2536 (Fig 5.2C). Thus, BI 2536 induces premature separation of sisters 
indicating that Plk1 is required for the crucial function of protecting 
centromeric cohesin during MI.  
 
5.8.1.3 Post-PBE inhibition of Plk1 does not promote premature sister separation 
Given that separated sisters were detected in oocytes that had already exited 
MI, it was important to determine whether sister separation occurred during 
exit form MI or during MII arrest.  To distinguish between these two 
possibilities, I incubated oocytes in BI 2536 shortly after PBE and prepared 
chromosome spreads to assess the extent of sister separation. I found no 
significant differences in the number of single sisters between BI 2536-treated 
and control oocytes (Fig 5.3B/C). Therefore, it is likely that the single 
chromatids arise during anaphase I, when cohesin is normally removed from 
chromosome arms, but is retained at centromeres.  
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5.8.1.4 Centromeric cohesin is not depleted during prometaphase I in BI 2536-treated 
oocytes. 
Having established that inhibition of Plk1 induces premature separation of 
sisters, I asked whether centromeric cohesin was already depleted before the 
onset of anaphase. To test this idea I measured intercentromeric distances and 
levels of centromeric cohesin in control and BI 2536-treated Rec8-myc oocytes at 
late prometaphase of MI. Consistent with my previous observations in oocytes 
from CD1 mice (Fig 4.7), BI 2536 caused an increase in the intercentromeric 
distances at late prometaphase of MI (5.4D). However, the results indicate that 
centromeric cohesin was not depleted during late prometaphase in BI 2536-
treated oocytes. These data, together with absence of an effect on MetII oocytes, 
imply that Plk1 is required to protect centromeric cohesin during anaphase of 
MI, rather than before or after it. 
 
5.8.1.4 BI 2536 compromises centromeric Sgo2-PP2A localisation in prometaphase of 
MI 
In yeast and vertebrate meiosis, Rec8 must be phosphorylated in order to be 
cleaved by separase during anaphase I (Lee and Amon, 2003; Kudo et al., 2009; 
Katis et al., 2010; Rumpf et al., 2010). To prevent precocious separation of sister 
chromatids in MI, centromeric cohesin must be protected/de-phosphorylated. 
In both budding and fission yeast this is achieved through the phosphatase 
activity of PP2A, which is recruited to the centromere by Sgo1 and counteracts 
phosphorylation of Rec8 (Kitajima et al., 2006; Riedel et al., 2006). In mouse 
meiocytes, Sgo2 is responsible for recruitment of PP2A and protection of 
centromeric cohesin during MI (Lee et al., 2008). Previous studies have shown 
that Aurora B and Bub1 are required for centromeric recruitment of Sgo2 in 
vertebrate somatic cells (Huang et al., 2007) and that Bub1 might be involved in 
the recruitment of shugoshin proteins to centromeres in mouse oocytes 
(McGuinness et al., 2009) . Could Plk1 activity at the centromere somehow also 
be involved in this process?  
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To test the idea that loss of centromeric cohesin during anaphase of MI was due 
to impaired protection, I asked whether Sgo2 and PP2A, are recruited to 
centromeres in the presence of BI 2536. Immunolabelling for Sgo2 and PP2A 
revealed a striking difference in the centromeric localisation of the Sgo2-PP2A 
complex between control and BI 2536-treated oocytes, with the latter being 
characterised by sister centromeres where Sgo2-PP2A was displaced from the 
centre of the centromeres (Fig 5.5). Presuming that Sgo2-PP2A should localise 
physically close to centromeric cohesin, in order to fulfill its protective role, 
then the off-centred positioning of Sgo2-PP2A is unlikely to be effective in 
protecting the cohesin complexes between sister centromeres from cleavage by 
separase.  
 
It remains to be established whether mislocalisation of Sgo2 and PP2A is linked 
to the increased distance between sister centromeres observed in BI 2536-
treated oocytes.  The reason for the increased distance between sisters is also 
obscure, but it may be linked to the hyper-condensed state of the chromatin in 
the presence of BI 2536.  In other words, hyper-condensation of pericentromeric 
chromatin may push sister centromeres apart.  An alternative possibility is that 
Plk1 is required for monopolar attachment and that the increased distance 
between sisters is caused by bi-oriented sisters being pulled towards opposite 
poles. However, my analysis of kinetochore-microtubule attachments presented 
in the previous chapter provided no convincing evidence that biorientation of 
sisters is prevalent during MI in BI 2536-treated oocytes.  Taken together the 
data suggest that that mislocalisation of Sgo2, due to either a direct or indirect 
effect of Plk1 inhibition, is sufficient to explain loss of centromeric cohesin 
during anaphase of MI. 
 
Further experimentation to dissect the mechanisms of Plk1 function would 
involve the use of nocodazole or taxol in order to examine whether absence of 
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Mt attachments or tension, respectively, alters the observed effect of BI 2536 on 
Sgo2-PP2A localisation. The effects of hyper-condensation would be harder to 
assess, as I am not currently aware of a method that could counteract this effect 
of BI 2536 on chromosome condensation, without interfering with other known 
Plk1 functions. 
5.8.2 No evidence of prophase pathway-like activity in MI 
In vertebrate mitosis, the bulk of chromosome arm-associated cohesin is 
removed during prometaphase by phosphorylation of the SA2 (and 
presumably SA1) cohesin subunit by Plk1; this process is separase-independent 
and is referred to as the prophase pathway (Waizenegger et al., 2000; Sumara et 
al., 2002; Hauf et al., 2005). The presence or absence of this pathway has not yet 
been experimentally confirmed in vertebrate meiocytes, although Plk1 has been 
shown to be highly active during prometaphase I in mouse oocytes (Pahlavan et 
al., 2000). It seems logical though to presume that the prophase pathway is very 
tightly regulated, if not completely inhibited, as precocious removal of arm 
cohesin prior to anaphase I would result in premature resolution of chiasmata 
leading to devastating effects for meiosis (Roeder, 1997). However, this 
assumption does not exclude the possibility that Plk1 kinase activity might 
somehow contribute to arm-associated cohesin depletion in oocytes during the 
prolonged prophase arrest stage and/or the prometaphase I stage, which lasts 
longer in meiosis (~6h, mouse; ~20h, human) than in mitosis (~45min, human). 
Such an effect of Plk1 during meiotic maturation would have adverse effects 
especially on aged oocytes as these oocytes both spend more time in prophase 
arrest and resume MI with depleted levels of chromosome associated cohesin 
(Chapter 1).  
 
To test the hypothesis that Plk1 activity might contribute to cohesin depletion 
during prometaphase I, I initially decided to inhibit it and examine for 
differences in chromosome arm-associated cohesin levels at late prometaphase 
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of MI in oocytes from young (8wks old) Rec8-myc mice. Unfortunately, this 
approach proved inefficient, because the combination of high levels of cohesin 
in young oocytes and chromosome hyper-condensation rendered my immuno-
fluorescence intensity quantification methods non-applicable. To overcome this 
I decided to follow the same approach, but to use oocytes from aged mice 
instead, assuming that a change in cohesin levels would be more 
distinguishable when using oocytes with already depleted levels of 
chromosome-associated cohesin. The results (Fig 5.6) revealed no apparent 
difference in the levels of chromosome-associated Rec8 between control and BI 
2536-treated oocytes. In contrast to what has been shown in mitotic cells (Lenart 
et al., 2007), these data suggest that Plk1-mediated removal of cohesin is 
negligible, I any, in mouse oocytes. It could be argued that Plk1 activity might 
be removing Scc1-containing cohesin, instead of Rec8-containing ones, from 
chromosomes during prophase and/or prometaphase I. However, a recent 
study suggested that Scc1-containing cohesin does not contribute to sister 
chromatid cohesion in MI (Tachibana-Konwalski et al., 2010). 
 
Assuming that Plk1 activity actually poses a threat to arm-associated cohesin 
during prometaphase of MI, what might be the protection mechanisms against 
it? In mitosis separase-independent removal of cohesin through the prophase 
pathway is achieved through Plk1-dependent phosphorylation of its SA2 
subunit (Hauf et al., 2005). However, in invertebrate meiocytes SA1 and SA2 
subunits are replaced by the meiosis-specific SA3 (Prieto et al., 2001). I have 
used Clustal Omega (http://www.ebi.ac.uk/Tools/msa/clustalo/) to align the 
nucleotide sequences of   SA1, SA2 and SA3 and I found that although all the 
known Plk1 phosphorylation sites on SA2 (Hauf et al., 2005) are conserved in 
SA1, only 5 out of 21 (~24%) are conserved in SA3 (data not shown). 
Unfortunately, my limited bioinformatics knowledge has not allowed me to 
investigate for putative Plk1 binding sites on SA3. Could this reduction in Plk1 
phosphorylation sites indicate a role for SA3 in protecting arm-associated 
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cohesin from Plk1 activity? This hypothesis would actually be consistent with 
previous findings showing that in mammalian oocytes SA3 localises to the 
interchromatid domain during prometaphase I, but is not detected on 
chromosomes after anaphase I (Prieto et al., 2001). Further research in our lab 
(Randy Ballesteros) has shown that Plk1 is mostly kept outside the nucleus 
during oocyte growth suggesting another mechanism in place for restricting 
putative Plk1 effects on chromosomal cohesin during prophase arrest. Taken 
together the above data indicate that Plk1 is not likely to be a major contributor 
to its loss during mammalian female reproductive ageing.  
 
In summary, my findings indicate that the major role of Plk1 in relation to the 
regulation of cohesin, rests in the protection of centromeric cohesin from 
separase during anaphase I, rather than in the removal of arm cohesin via a 
meiotic equivalent of the prophase pathway.  
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 . Conclusion & Future Directions Chapter 6
 
The work described in this thesis makes a significant contribution towards a 
better understanding of the mechanisms regulating chromosome segregation in 
mammalian oocytes. This was achieved by pursuing three lines of investigation: 
1) The effect of ageing on cohesin and its protector, Sgo2; 2) Characterisation of 
Plk1 function in oocytes; 3) The role of Plk1 in cohesin protection and removal 
in oocyte meiosis. 
6.1 Cohesin and female reproductive ageing 
During recent years evidence is accumulating to support the hypothesis that 
cohesin deterioration is an age-dependent process and correlates with an 
increasing incidence of aneuploidies (Hodges et al., 2005; Liu and Keefe, 2008; 
Chiang et al., 2010; Lister et al., 2010; Chiang et al., 2011). 
 
In support of the above, in this thesis I show that age-related depletion of 
chromosomal cohesin occurs during the prolonged period of prophase arrest 
experienced by oocytes from older females. I also document an increase in 
intercentromere distance in older oocytes. Interestingly, I also find that the 
cohesin protector Sgo2 is also reduced with increasing age, that it is not 
recruited to chromosomes until the transition from prophase to prometaphase 
of MI and that its recruitment is impaired in cohesin-deficient oocytes. On the 
basis of these findings, we propose a scenario where the depletion of cohesin 
during the extended prophase arrest causes impaired recruitment or retention 
of Sgo2 to chromosomes during late prophase, which in turn renders the 
remaining cohesin vulnerable to removal during prometaphase I resulting in 
disruption of the unique chromosome architecture required for normal 
segregation of homologues during anaphase of MI. 
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Support for this model comes from recent findings in mouse oocytes that 
bivalent stability depends on cohesin complexes loaded in S-phase (Revenkova 
et al., 2010; Tachibana-Konwalski et al., 2010). This also implies that intervention 
strategies based on replenishment of cohesin are not likely to rescue age-related 
defects. Thus, the immediate focus of future research would be to uncover the 
primary mechanisms of cohesin loss and to determine whether the model can 
be applied to reproductive ageing in women. 
 
Depletion of chromosome- associated cohesin in oocytes of older females may 
be a consequence of protein damage, or removal by a separase-independent or 
separase-dependent pathway. In support of the latter, preliminary experiments 
in our lab indicate that separase is expressed in prophase-arrested mouse 
oocytes. This is consistent with findings in budding yeast (Katis et al., 2010) and 
raises the possibility that even a very low level of separase activity might result 
in significant depletion of cohesin during the extended period of prophase 
arrest in aged females. 
 
Another important question is whether cohesin loss occurs during the relatively 
quiescent primordial stage and whether it occurs uniformly across all stages of 
oocyte development. A marked difference between young and aged oocytes at 
the primordial stage would be consistent with a gradual loss of cohesin during 
prolonged prophase arrest. By contrast, if the difference becomes apparent only 
in growing oocytes, it could be speculated that the age-related depletion of 
cohesin is linked either to movement of the cohesin ring during the massive 
burst of transcriptional activity (Kagey et al., 2010), and/or due to protein 
damage associated with increased metabolic activity. Answering these 
questions is crucial to understanding the underlying mechanisms of cohesin 
loss and to gaining insight into the feasibility of preventative strategies. 
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6.2 Plk1 function in mouse oocytes and its association with cohesin 
The previously reported (Wianny et al., 1998) association of Plk1 with meiotic 
chromosomes, has received very little attention in studies of the enzyme in 
mammalian meiosis. Consistent with what has been observed in mitotic cells 
(Petronczki et al., 2008), the punctate localisation of Plk1 that I have described in 
this thesis leaves no doubt that it associates with the kinetochore region of 
meiotic chromosomes. Importantly, by using a low concentration of BI 2536, I 
have unmasked a function for Plk1 in protecting centromeric cohesin during 
anaphase of MI. My findings indicate that loss of centromeric cohesin in the 
presence of BI 2536 is due to mislocalisation of the cohesin protector Sgo2. 
These findings indicate that Plk1 is required not only for accurate kinetochore 
function, but also for accurate chromosome segregation during meiosis. It is 
interesting how Plk1 almost disappears from the kinetochore region of Met-II 
chromosomes, which no longer necessitate protection of centromeric cohesion 
by Sgo2. 
 
An additional important finding is that APC/C activation in MI appears to be 
Plk1-dependent. This contrasts with findings in mitosis where Plk1 inhibition 
leads to prometaphase arrest by activating the SAC and not through an effect 
on the core APC/C (Lenart et al., 2007). The key question that needs to be 
answered in the future is whether Plk1 is required to suppress an inhibitor of 
the APC/C in meiosis or whether phosphorylation by Plk1 is required for 
efficient activation of the APC/C during exit from MI. 
 
Moreover, the finding that inhibition of Plk1 activity, permissive for anaphase 
to occur, had no effect on MI chromosome segregation indicates that Rec8 
and/or separase phosphorylation by Plk1 is not required for Rec8 cleavage by 
separase. This finding challenges a previous report that phosphorylation by 
Plk1 is essential for mouse Rec8 cleavage by separase in vitro (Kudo et al., 2009). 
It is conceivable that either Rec8 phosphorylation by Plk1 is not important for 
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MI chromosome segregation or there are additional protein kinases 
phosphorylating Rec8 in vivo. However, we cannot at this stage exclude the 
possibility that residual Plk1 activity was present at the concentrations of BI 
2536 used in the experiments described in this thesis. 
 
Finally, I have investigated for evidence of Plk1-mediated removal of cohesin 
from meiotic chromosomes in a mechanism analogous to the prophase 
pathway. I present data indicating that removal of cohesin by a Plk1-mediated 
mechanism is unlikely to be a major mechanism of cohesin removal during 
prometaphase of MI and is therefore unlikely to contribute to an age-related 
loss of cohesin during progression through prometaphase. This triggers the 
question of how is arm-cohesin immunized against Plk1 activity, which is 
highly active during the prolonged prometaphase of MI in oocytes. 
 
Plk1 has already been assigned a plethora of roles in mitosis; therefore it is not 
surprising to discover similar or additional functions in meiosis. However, we 
cannot exclude the possibility that the observed chromatin hyper-condensation 
in the presence of BI 2536 might cause deformations of the centromere and 
kinetochore, thus further interrupting the balance between levels of kinase-
phosphatase activities at kinetochores, which is known to depend highly on 
Plk1 activity (Archambault and Carmena, 2012). 
 
Taken together, our findings indicate that Plk1 has previously unknown 
functions during mammalian meiosis involving activation of the APC/C and 
stepwise removal of cohesin, both of which are essential for normal segregation 
of chromosomes. Moreover, we show that Plk1 activity is not likely to be a 
major contributor to cohesin loss during mammalian female ageing. The 
identification of Plk1’s exact role and position in the molecular pathways that 
govern these processes during meiosis remain to be elucidated. Although the 
small-molecule inhibitors BI 2536 has proven to be a fantastic research tool for 
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dissecting the spatio-temporal function of Plk1, further research into the 
molecular mechanisms will necessitate different approaches.  
6.3 Clinical Relevance 
Female ageing is the most important aetiological factor for genetic 
abnormalities and infertility in humans (Nagaoka et al., 2012). Despite this, 
recent birth statistics show that the number of babies born to mothers older 
than 35 years of age increased by 46% between 1996 and 2006 (Morris and 
Alberman, 2009). The impact of this on human reproductive health is 
highlighted by a 70% increase in the incidence of Down’s syndrome pregnancy 
during the past 20 years (Morris and Alberman, 2009). The trend for women to 
delay childbearing also has enormous implications for general health, wellbeing 
and socio-economic stability. For example, a report from the actuarial 
profession in the UK (More babies? Who needs them?, 2004) predicts that the 
declining birth rate will reduce the support ratio (defined as the number of 
working people per person aged >65 years) from 3.9 in 2004 to 2.2 by 2050. 
Thus, the trend for women to postpone reproduction is a double-edged sword, 
which cuts the support ratio while creating the additional problems of age-
related infertility and health care demands of prenatal testing, pregnancy 
terminations and, in the event of birth defects, care of the disabled. The work 
presented in this thesis constitutes a significant step towards understanding the 
primary causes of female age-related chromosome defects.  This will provide us 
with insights into the feasibility of developing strategies to prevent or reduce 
cohesin loss.  
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Abbreviations 
Ama1  Activator of meiotic anaphase complex  
APC/C  Anaphase promoting complex/ Cyclosome  
Ark1 
ATP 
Aurora kinase 1 
Adenosine tri-phosphate  
Bub1-3  Budding uninhibited by benzimidazoles 1-3 homolog  
BubR1  
BSA 
Budding uninhibited by benzimidazoles 1 homologue beta 
Bovine serum albumin 
cAMP  Cyclic adenosine mono-phosphate  
Cdc20  Cell division cycle 20  
Cdh1  Cell division cycle 20 homologue 1  
Cdk1  Cell dependent kinase 1  
cDNA  Complementary DNA  
CENP A-F  Centromeric protein A-F  
CO2  Carbon dioxide  
CPC  Chromosomal passenger complex  
CREST  Calcinosis, Raynaud phenomenon, esophageal  
 dismotility, sclerodactyly, telangiectasia  
CSF  Cytostatic factor  
Cyclin B1-GFP  Green fluorescent tagged cyclin B1  
DAPI  4’,6-diamidino-2-phenylindole  
DIC  Differential interference contrast  
DNA  Deoxyribonucleic acid  
DTT  Dithiothreitol  
FSH  Follicle stimulating hormone  
GAPDH  Glyceraldehyde 3-phosphate dehydrogenase  
GFP  Green fluorescent protein  
GV  Germinal vesicle  
GVBD  Germinal vesicle breakdown  
H2B-RFP  Histone 2B-red fluorescent protein  
IBMX  Isobutylmethylxanthine  
LH  Luteinising hormone  
Mad2  Mitotic-arrest deficient 2  
MAPK  Mitogen-activated protein kinase  
MCC Mitotic checkpoint complex 
ME-S332  Meiotic from Salaria 332  
MetI  Metaphase I  
MetII  Metaphase II  
MI 
g 
l  
Meiosis I 
Microgram 
Microliter  
m  Micrometre  
M  Micromolar  
MII  Meiosis II  
mM  Millimolar  
M  Molar  
mRNA  Messenger RNA  
MTOC Microtubule organizing centre 
 123 
Myc 
na  
Myelocytomatosis viral oncogene  
Numerical Aperture 
NaOH Sodium hydroxide 
NEBD  Nuclear envelope breakdown  
NLS  
nM 
Nuclear localisation sequence 
Nanomolar 
PB  Polar body  
PBE  Polar body extrusion  
PBS  Phosphate buffered saline  
PCR  Polymerase chain reaction  
PFA  Paraformaldehyde  
PGC  Primordial germ cell  
Plk1/Plx1  Polo-like kinase 1  
PMSG  Pregnant mare serum gonodotrophin  
PP2A  Protein phosphastase 2A  
Rad21  Double strand break repair protein Rad21 homologue  
Rec8  Meiotic recombination protein Rec8 homologue  
RFP  Red fluorescence protein  
RNAi  Ribonucleic acid interference  
RNAse  Ribonuclease  
RT  Room temperature  
SA1-3  Stromal antigen protein 1-3  
SAC  Spindle assembly checkpoint  
SAM  Senescence accelerated mouse  
Scc1-4  Sister chromatid cohesion protein 1-4  
Sgo1-2 Shugoshin 1-2 
siRNA Small interference RNA 
Smc1-3 Structural maintenance of chromosomes 1-3 
Sycp3 Synaptonemal complex protein 3 
UTR Untranslated region 
v/v By volume 
w/v By weight 
YFP Yellow fluorescent protein 
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